Document:

QuickLinks
 -- Click here to rapidly navigate through this document
  

Exhibit 4.10  

 
 

MANAGEMENT EQUITY AGREEMENT    
    

        THIS MANAGEMENT EQUITY AGREEMENT (this "Agreement") is made as of February 6, 2004, among JSG Packaging
Limited, a private limited company organized under the laws of Ireland (the "Company"), and each of executives that become party hereto from time to
time pursuant to the Management Equity Plan (as hereinafter defined) by executing a signature page to be attached hereto (each an "Executive"). 

        The
Company and each Executive desire to enter into an agreement pursuant to which such Executive shall exchange, and the Company shall issue, one of the Company's Ordinary Shares,
nominal value €0.001 per share (the "Ordinary Shares"), and one of the Company's Class A Convertible Shares, Class B
Convertible Shares and Class C Convertible Shares in exchange for each Ordinary Share, Class A Convertible Share, Class B Convertible Share and Class C Convertible Share
held by the Executive in Jefferson Smurfit Group Limited (formerly MDCP Acquisitions Limited). The exchange and issuance referred to in the immediately foregoing sentence is being consummated in
connection with the exchange of each issued and outstanding Ordinary Share, Class A Convertible Share, Class B Convertible Share and Class C Convertible Share of Jefferson Smurfit
Group Limited (the "JSG Shares") for one Ordinary Share, Class A Convertible Share, Class B Convertible Share and Class C
Convertible Share of the Company, respectively (including as may result from any compulsory share acquisition under Section 204 of the Irish Companies Act, such transaction, the
"Exchange"). The Ordinary Shares and Convertible Shares to be acquired by an Executive hereunder are being issued pursuant to and subject to the JSG
Packaging Limited 2004 Management Equity Plan, a copy of which is attached as Annex A hereto (as amended from time to time in accordance with its terms,
the "Management Equity Plan"). On the date that the exchange of all JSG Shares for shares of the Company is consummated (including after giving effect
to the compulsory acquisition procedure set forth in Section 204 of the Irish Companies Act 1963), the rights and obligations of the parties pursuant to that certain Amended and Restated
Management Equity Agreement, dated as of September 5, 2002, by and among Jefferson Smurfit Group Limited and the Executives shall be terminated in its entirety. Capitalized terms not otherwise
defined herein have the meanings set forth in paragraph 10 of this Agreement. 

        The
parties hereto agree as follows: 

        1.    Exchange of Ordinary Shares.    

        (a)    Exchange.    At the Closing (as defined in paragraph 1(b) hereof), each Executive shall deliver to the
Company, all of Executive's right, title and interest in each Ordinary Share of Jefferson Smurfit Group Limited owned by such Executive in exchange for one Ordinary Share of the Company, such that
after giving effect to such exchange, Executive shall own an identical number of Ordinary Shares of the Company as the number of Ordinary Shares of Jefferson Smurfit Group Limited owned by such
Executive. 

        (b)    The Closing.    The closing of the exchange and issuance of the Ordinary Shares (the
"Closing") shall take place at the offices of the Company at 10:00 a.m. on February 6, 2004 (or, in the event that any Executive has not
executed and delivered this Agreement prior to such date, the Closing shall be deemed to occur for such Executive on the date that the compulsory share acquisition under Section 204 of the
Irish Companies Act is consummated). At the Closing, the Company shall enter such Executive's name or, if applicable, the name of his nominee or custodian, on the Company's register of members as the
holder of the number of Ordinary Shares set forth on such Executive's signature page attached hereto, and such Executive shall deliver to the Company all of Executive's right, title and interest in
and to the Ordinary Shares of Jefferson Smurfit Group Limited being exchanged hereunder. 

1

 

        (c)    Family Member.    In the event that any Executive transferred any Ordinary Shares or Convertible Shares of
Jefferson Smurfit Group Limited to any Family Member, such Executive shall procure the exchange and delivery of the Ordinary Shares and Convertible Shares by such Family Member and, in the event that
any Ordinary Shares or Convertible Shares of the Company are held by any Family Member (including as a result of transfer after the date hereof), the rights, obligations, restrictions and conditions
applicable to Executive Stock pursuant to this Agreement will be applicable to shares of such Executive Stock issued to or held by any Family Member as if held by such Executive and the issue or
transfer to such Family Member shall be conditional upon such Family Member having agreed in writing to be bound by the provisions of this Agreement. 

        2.    Exchange of Convertible Shares.    

        (a)    Exchange.    On the Closing Date, each Executive shall deliver to the Company all of Executive's right, title
and interest in each Class A Convertible Share of Jefferson Smurfit Group Limited, each Class B Convertible Share of Jefferson Smurfit Group Limited and each Class C Convertible
Share of Jefferson
Smurfit Group Limited owned by such Executive in exchange for, respectively, one Class A Convertible Share of the Company, one Class B Convertible Share of the Company and one
Class C Convertible Share of the Company such that after giving effect to such exchange, Executive shall own an identical number of Class A Convertible Shares, Class B Convertible
Shares and Class C Convertible Shares of the Company as the number of Class A Convertible Shares, Class B Convertible Shares and Class C Convertible Shares of Jefferson
Smurfit Group Limited owned by such Executive. On the Closing Date, the Company shall enter such Executive's name or, if applicable, the name of his nominee or custodian, on the Company's register of
members as the holder of the number of Convertible Shares purchased by such Executive hereunder, and such Executive shall deliver to the Company all of Executive's right, title and interest in and to
the Ordinary Shares of Jefferson Smurfit Group Limited being exchanged hereunder. 

        (b)    Convertibility of Class A Convertible Shares, Class B Convertible Shares and Class C Convertible
Shares.    Each Class A Convertible Share, Class B Convertible Share and Class C Convertible Share will automatically convert into one
Class D Convertible Share in accordance with this Agreement once it has fully vested. 

        (c)    Vesting.    Subject to paragraph 2(d): 

          (i)  Each
Executive's Class A Convertible Shares shall become vested in accordance with the following schedule, if, but only if, as of each such date such Executive
is and has continued to be employed by or to serve as an officer or director for the Company and its Subsidiaries: 

	Vesting Date
	 	Cumulative Percentage of

Class A Convertible

Shares Vested
	 
	December 31, 2005	 	33.3	%
	December 31, 2006	 	66.7	%
	December 31, 2007	 	100	%

None
of an Executive's Class A Convertible Shares shall become vested if such Executive ceases to be employed by, or to serve as an officer or director for, the Company or its Subsidiaries
prior to December 31, 2005. If any Executive ceases to be employed by, or to serve as an officer or director for, the Company or its Subsidiaries on any date other than any Vesting Date set
forth in this paragraph 2(c)(i) after December 31, 2005 but prior to December 31, 2007, the cumulative percentage of such
Executive's Class A Cumulative Shares to become vested shall be determined on a pro rata basis according to the number of days elapsed since the immediately preceding Vesting Date.
Notwithstanding the foregoing, upon the occurrence of a Sale of the Company or a Listing, all of an Executive's Class A Convertible Shares which have not previously vested shall become vested
and shall convert to an equal number of Class D Convertible Shares upon the 

2

 

occurrence
of such event; provided that no Class A Convertible Shares shall vest for any Executive (or Executive's transferees) upon the
occurrence of a Sale of the Company or a Listing if the Executive holding such Class A Convertible Shares or from whom the Class A Convertible Shares were transferred is no longer
employed by, or no longer serves as an officer or director for, the Company and its Subsidiaries as of the date of the occurrence of the Sale of the Company or a Listing. 

         (ii)  33.3%
of the aggregate number of each Executive's Class B Convertible Shares issued to him pursuant to  paragraph 2(a) will become vested on each Applicable Class B Valuation Date if, but only
if, the IRR of the MDCP Co-Investors
as of such Applicable Class B Valuation Date equals or exceeds 25%; provided that if the IRR of the MDCP Co-Investors as of such
Applicable Class B Valuation Date is greater than 15%, but less than 25%, the percentage of the aggregate Class B Convertible Shares which will become vested as of such Applicable
Class B Valuation Date shall be the percentage determined by multiplying 3.33 by the excess of (A) the IRR of the MDCP Co-Investors as of the Applicable Class B
Valuation Date over (B) 15%. In the event that an Accelerated Valuation Date occurs prior to any Applicable Class B Valuation Date, 100% of the Class B Convertible Shares not
previously vested pursuant to this paragraph 2(c)(ii) will become vested as of such Accelerated Valuation Date if, but only if, the IRR of the
MDCP Co-Investors as of such Accelerated Valuation Date equals or exceeds 25%; provided that if the IRR of the MDCP Co-Investors
as of the Accelerated Valuation Date is greater than 15%, but less than 25%, the percentage of Eligible Class B Convertible Shares which shall vest as of such Accelerated Valuation Date shall
be the percentage determined by multiplying 10 by the excess of (A) the IRR of the MDCP Co-Investors as of the Accelerated Valuation Date over (B) 15%. Vesting with respect
to the Class B Convertible Shares shall be cumulative such that if the IRR of the MDCP Co-Investors as of an Accelerated Valuation Date or any subsequent Applicable Class B
Valuation Date is greater than any preceding Applicable Class B Valuation Date, the percentage of each Executive's entire holding of Class B Convertible Shares vested shall be
recalculated to be equal to the percentage vested for such Accelerated Valuation Date or subsequent Applicable Class B Valuation Date (i.e., if the IRR of the MDCP Co-Investors as
of a preceding Applicable Class B Valuation Date was 15% and the IRR of the MDCP Co-Investors as of a subsequent Applicable Class B Valuation Date is 20%, the aggregate
percentage of Class B Convertible Shares vested (inclusive of Class B Convertible Shares already vested as of such preceding Applicable Class B Valuation Date) with respect to
both Applicable Class B Valuation Dates shall be, effective as of the subsequent Applicable Class B Valuation Date, 50%). For the avoidance of doubt, in the event that an Accelerated
Valuation Date arises prior to any Applicable Class B Valuation Date, the determination of vesting with respect to all unvested Class B Convertible Shares otherwise eligible for vesting
on any subsequent Applicable Class B Valuation Date shall be made solely as of such Accelerated Valuation Date and shall not be re-eligible for vesting as of such subsequent
Applicable Class B
Valuation Date. Notwithstanding anything else to the contrary set forth in this paragraph 2(c)(ii), no Class B Convertible Shares shall
vest for any Executive (or Executive's transferees) as of any Applicable Class B Valuation Date or Accelerated Valuation Date if the Executive holding such Class B Convertible Shares or
from whom the Class B Convertible Shares were transferred is no longer employed by, or no longer serves as an officer, or director for, the Company and its Subsidiaries as of such Applicable
Class B Valuation Date or Accelerated Valuation Date. 

        (iii)  100%
of each Executive's Class C Convertible Shares will become vested on the Class C Valuation Date if, but only if, the IRR of the MDCP
Co-Investors as of the Class C Valuation Date is equal to or greater than 30%. In the event that an Accelerated Valuation Date occurs prior to the Class C Valuation Date,
100% of the Class C Convertible Shares will become vested as of such Accelerated Valuation Date if, but only if, the IRR of the MDCP Co-Investors as of such Accelerated Valuation
Date is equal to or greater than 30%. For the avoidance of doubt, in 

3

 

the
event that an Accelerated Valuation Date arises prior to the Class C Valuation Date, the determination of vesting with respect to all unvested Class C Convertible Shares otherwise
eligible for vesting on the subsequent Class C Valuation Date shall be made solely as of such Accelerated Valuation Date and shall not be re-eligible for vesting as of such
subsequent Class C Valuation Date. Notwithstanding anything else to the contrary set forth in this paragraph 2(c)(iii), no Class C
Convertible Shares shall vest for any Executive (or Executive's transferees) as of the Class C Valuation Date or Accelerated Valuation Date if the Executive holding such Class C
Convertible Shares or from whom the Class C Convertible Shares were transferred is no longer employed by, or no longer serves as an officer or director for, the Company and its Subsidiaries as
of such Class C Valuation Date or Accelerated Valuation Date. 

        (iv)  Notwithstanding
the provisions of paragraphs (i), (ii) and (iii), as a condition to accelerated vesting of such Executive's Convertible Shares in connection with
a Sale of the Company, such Executive shall, if requested by the purchaser of the Company and for no additional consideration therefor, agree to continued employment for up to 12 months
following such Sale of the Company so long as such Executive's compensation package and job description immediately following such Sale of the Company is substantially similar with respect to
remuneration (other than with respect to equity participation), scope of duties, responsibility and job location to such Executive's compensation package and job description immediately prior to such
event. 

         (v)  The
IRR of the MDCP Co-Investors on any Applicable Valuation Date shall be determined with reference to the Total Value of the Company and its Subsidiaries
as of such Applicable Valuation Date, which Total Value (including the components thereof) shall be determined, to the extent possible, on the basis of the audited annual financial statements for the
Company and its Subsidiaries for the period ended on such Applicable Valuation Date and otherwise in good faith by the Company. The IRR of the MDCP Co-Investors as of such Applicable
Valuation Date shall be calculated (A) assuming that on such Applicable Valuation Date, the MDCP Co-Investors are receiving Cash Inflows for any Preferred Equity Securities equal to
the stated value thereof plus accrued but unpaid dividends thereon and with respect to its Ordinary Shares is receiving Cash Inflows equal to the Total Value multiplied by the percentage of
fully-diluted Ordinary Shares of the Company held by the MDCP Co-Investors as of such Applicable Valuation Date and (B) with regard to all sales of equity securities prior to such
Applicable Valuation Date by calculating all Cash Inflows received or receivable with respect to such equity securities sold prior to such Applicable Valuation Date. The IRR of the MDCP
Co-Investors on an Accelerated Valuation Date that arises as a result of a Sale of the Company shall be determined on the basis of the aggregate Cash Inflows received or receivable by the
MDCP Co-Investors in respect of all sales of equity securities of the Company by the MDCP Co-Investors through and including such Accelerated Valuation Date (and in the event
that the MDCP Co-Investors have not sold all of their equity securities as of such Accelerated Valuation Date, assuming that the MDCP Co-Investors would sell their remaining
Preferred Equity Securities at an amount equal to the stated value thereof plus accrued and unpaid dividends thereon and its remaining Ordinary Shares at the average price per share received or
receivable by the MDCP Co-Investors in respect of their Ordinary Shares through such Accelerated Valuation Date). The IRR of the MDCP Co-Investors on an Accelerated Valuation
Date that arises as a result of a Listing shall be determined assuming that the MDCP Co-Investors will receive Cash Inflows on such Accelerated Valuation Date with respect to all of their
then-outstanding Ordinary Shares at the gross per share offering price for Ordinary Shares on the date that the Listing becomes effective (the "Offering
Price") and will receive Cash Inflows in respect of all of their then-outstanding Preferred Equity Securities in an amount equal to the stated value thereof plus
accrued and unpaid dividends (with it being understood that all Cash Outflows and Cash Inflows for the MDCP Co-Investors with respect to Ordinary Shares sold prior to the date of such
Listing 

4

 

shall
be disregarded in calculating IRR of the MDCP Co-Investors on an Accelerated Valuation Date that arises as a result of a Listing). 

        (vi)  In
determining IRR of the MDCP Co-Investors for purposes of calculating vesting with respect to Class B Convertible Shares, as of any date of
determination, all Class A Convertible Shares shall be assumed to have vested and been converted into Class D Convertible Shares, a number of Class B Convertible Shares that would
be vested and convertible as a result of the IRR calculation as of the date of determination shall be assumed to have vested and been converted into Class D Convertible Shares, no
Class C Convertible Shares shall be assumed to have vested and been converted into Class D Convertible Shares and all Class D Convertible Shares (including as assumed issued as a
result of this sentence) shall be assumed to have been converted into Ordinary Shares. In determining IRR of the MDCP Co-Investors for purposes of calculating vesting with respect to the
Class C Convertible Shares, as of any date of determination, all Class A Convertible Shares, Class B Convertible Shares and Class C Convertible Shares shall be assumed to
have vested and been converted
into Class D Convertible Shares and all Class D Convertible Shares (including as assumed issued as a result of this sentence) shall be assumed to have been converted into Ordinary
Shares. 

       (vii)  In
addition to the vesting otherwise herein described, all or any portion of the Class A Convertible Shares, Class B Convertible Shares and
Class C Convertible Shares may be vested in the discretion of the Board exercised at any time. 

        (d)    Effect of Termination on Vesting.    If an Executive's employment with the Company terminates for any reason,
such Executive's Convertible Shares shall be vested and fully convertible with respect to that portion of such Executive's Convertible Shares that were vested and convertible on the date of such
termination (such Executive's "Termination Date"), and, unless otherwise determined by the Board, any portion of such Executive's Convertible Shares
that were not vested and convertible as of such Executive's Termination Date shall not vest from and after the Termination Date and shall not be convertible into Class D Convertible Shares from
and after the Termination Date. 

        (e)    Conversion Procedures for Class D Convertible Shares.    An Executive may, upon payment in full in cash
of the Conversion Price per share, convert all or any portion of his or her outstanding Class D Convertible Shares into Ordinary Shares at any time and from time to time. As a condition to any
conversion of any Class D Convertible Shares, such Executive shall make all investment representations as required by the Management Equity Plan. An Executive shall effect conversion of his
Class D Convertible Shares into Ordinary Shares by delivering (i) written notice of such conversion to the Company (to the attention of the Company's Chief Executive Officer or
Secretary), together with such Executive's written acknowledgment that he or she has read and has been afforded an opportunity to ask questions of management of the Company regarding all financial and
other information provided to or requested by such Executive regarding the Company and (ii) payment of an amount equal to the product of (A) the Conversion Price per share multiplied by
(B) the number of Ordinary Shares to be acquired upon such conversion. Payment of the conversion price for Class D Convertible Shares shall be made in cash (including check, bank draft
or money order) or, in the sole discretion of the Board, by delivery of a promissory note (if in accordance with policies approved by the Board). No Convertible Share issued hereunder or upon
conversion of any other class of Convertible Shares, shall be convertible after the seventh anniversary of the Underlying Date of Issuance. When used herein, the "Underlying Date of Issuance" means
(i) with respect to any Class A Convertible Share, Class B Convertible Share or Class C Convertible Share, the date of issuance for such Convertible Share (or in the event
that such Convertible Share was issued in exchange for a Convertible Share of Jefferson Smurfit Group Limited, the date of issuance of such Convertible Share of Jefferson Smurfit Group Limited) and
(ii) with respect to any Class D Convertible Share, the date of issuance for the Class A Convertible Share, the Class B Convertible Share or the Class C Convertible
Share from which such Class D Convertible Share has been converted. 

5

 

        3.    Representations and Warranties: Acknowledgments.    

        (a)   In
connection with the purchase and sale of Executive Stock, each Executive represents and warrants as follows: 

          (i)  Executive
Stock being acquired by such Executive pursuant to this Agreement shall not be disposed of in contravention of applicable securities laws. 

         (ii)  Such
Executive is sophisticated in financial matters and is able to evaluate the risks and benefits of the investment in the Executive Stock. 

        (iii)  Such
Executive is able to bear the economic risk of such Executive's investment in Executive Stock acquired hereunder for an indefinite period of time and acknowledges
that the Executive Stock may not be sold in contravention of applicable securities laws. 

        (iv)  This
Agreement constitutes the legal, valid and binding obligation of such Executive, enforceable in accordance with its terms, and the execution, delivery and
performance of this Agreement by such Executive do not and will not conflict with, violate or cause a breach of any agreement, contract or instrument to which such Executive is a party or any
judgment, order or decree to which such Executive is subject. 

         (v)  Such
Executive is the beneficial owner of all of the Ordinary Shares and Convertible Shares of Jefferson Smurfit Group Limited being exchanged hereunder free and clear
of all liens, encumbrances, charges, security interests, or restrictions on transfer. 

        (b)   As
an inducement to the Company to issue Executive Stock hereunder to each Executive, and as a condition thereto, each such Executive acknowledges and agrees that: 

          (i)  neither
the issuance of the Executive Stock hereunder to such Executive nor any provision contained herein shall entitle such Executive to remain in the employment of,
or to serve as an officer or director to, the Group Companies or affect the right of the Company to terminate such Executive's employment or service as an officer, or director at any time; 

         (ii)  this
Agreement and the Management Equity Plan shall not form part of any contract of employment or contract for services between the Company or any Subsidiary and each
Executive; 

        (iii)  the
benefit to each Executive of participation in this Agreement and the Management Equity Plan shall not form any part of his remuneration or count as his
remuneration for any purpose and shall not be pensionable; 

        (iv)  if
an Executive ceases to be employed by the Company or any Subsidiary, he shall not be entitled to compensation for the loss of any right or benefit or prospective
right or benefit under this Agreement and the Management Equity Plan whether by way of damages for unfair dismissal, wrongful dismissal, breach of contract or otherwise; and 

         (v)  the
Company shall have no duty or obligation to disclose to such Executive, and such Executive shall have no right to be advised of, any material information regarding
the Company and its Subsidiaries at any time prior to, upon or in connection with the repurchase of Executive Stock upon the termination of such Executive's employment with the Company and its
Subsidiaries, the transfer of Executive Stock pursuant to paragraphs 4, 5, or  8 hereto, the conversion of a
Convertible Share granted hereunder or as otherwise provided hereunder. 

        4.    Redemption Option.    

        (a)   In
the event (i) any Executive ceases to be employed by, or to serve as an officer, or director for, the Company or its Subsidiaries for any reason or,
(ii) a Corporate Family Member of an Executive ceases for any reason to be a Corporate Family Member of such Executive and thereafter fails to comply with the requirements of
paragraph 4(g) hereof or, (iii) any Corporate Family Member of an 

6

 

Executive
shall fail to comply with any requirement made pursuant to Clause 4(h) hereof (any such event being in respect of such Executive or Corporate Family Member, his or its
"Termination"), all of the Executive Stock held by such Executive or, as the case may be, such Corporate Family Member, other than Ordinary Shares
acquired pursuant to paragraph 1 hereof, (whether held by such Executive or Corporate Family Member or one or more of such Executive's transferees, "Redeemable
Stock") may be redeemed or purchased by the Company and/or the MDCP Co-Investors pursuant to the terms and conditions set forth in this paragraph 4 (the
"Redemption Option"). For the avoidance of doubt (but without prejudice to rights to redeem or purchase Ordinary Shares issued or issuable upon
conversion of convertible shares), Ordinary Shares acquired pursuant to paragraph 1 hereof are not subject to redemption or purchase pursuant to this paragraph 4 or otherwise. 

        (b)   In
the case of any Termination other than a termination of an Executive's employment for Cause, the purchase price for each Class A Convertible Share,
Class B Convertible Share and Class C Convertible Share shall be such Executive's Original Cost for such share, and the purchase price for each Class D Convertible Share and
Ordinary Share shall be the Fair Market Value for such share. In the event of an Executive's termination for Cause, the purchase price for each Convertible Share and each Ordinary Share shall be the
lower of (i) the Fair Market Value of such share and (ii) the Original Cost for such share. 

        (c)   The
Company may elect to redeem or purchase all or any portion of an Executive's Redeemable Stock by delivering written notice (the "Redemption
Notice") to the holder or holders of such Executive's Redeemable Stock within 90 days after such Executive's Termination (180 days in the case of such Executive's
Termination upon death or disability). The Redemption Notice shall set forth the number of shares of Redeemable Stock to be acquired from each holder of such Executive's Redeemable Stock, the
aggregate consideration to be paid for such shares and the time and place for the closing of the transaction. The number of shares to be redeemed or purchased by the Company shall first be satisfied
to the extent possible from the shares of Redeemable Stock held by such Executive at the time of delivery of the Redemption Notice. If the number of shares of Redeemable Stock then held by such
Executive is less than the total number of shares of Redeemable Stock the Company has elected to redeem or purchase, the Company shall purchase the remaining shares elected to be redeemed or purchased
from the other holder(s) of such Executive's Redeemable Stock under this Agreement, pro rata according to the number of shares of such Executive's Redeemable Stock held by such other holder(s) at the
time of delivery of such Redemption Notice (determined as close as practicable to the nearest whole shares). The number of shares of Redeemable Stock to be purchased hereunder shall be allocated among
such Executive and the other holders of such Executive's Redeemable Stock (if any) pro rata according to the number of shares of such Executive's Redeemable Stock to be purchased from such persons. 

        (d)   If
for any reason following an Executive's Termination, the Company does not elect to purchase all of such Executive's Redeemable Stock pursuant to the Redemption
Option, the MDCP Co-Investors shall be entitled to exercise the Redemption Option for the shares of Redeemable Stock the Company has not elected to purchase in accordance with  paragraph 4(c) (the
"Available Shares"). As soon as practicable after the Company has determined
that there will be Available Shares, but in any event within 45 days after such Executive's Termination, the Company shall give written notice (the "Redemption Option
Notice") to the MDCP Co-Investors setting forth the number of Available Shares and the aggregate purchase price therefor. The MDCP Co-Investors may
elect to purchase any or all of the Available Shares by giving written notice to the Company within 30 days after the Redemption Option Notice has been given by the Company. As soon as
practicable, and in any event within ten days after the expiration of the 30-day period set forth above, the Company shall notify each holder of Redeemable Stock as to the number of shares
being purchased from such holder hereunder by the MDCP Co-Investors (the "Supplemental Redemption Notice"). At the time the Company delivers
the Supplemental Redemption Notice to the holder(s) of Redeemable Stock, the Company shall also 

7

 

deliver
written notice to the MDCP Co-Investors setting forth the number of shares the MDCP Co-Investors are entitled to purchase, the aggregate purchase price and the time and
place of the closing of the transaction. The number of Class A Convertible Shares, Class B Convertible Shares, Class C Convertible Shares, Class D Convertible Shares and
Ordinary Shares to be repurchased under paragraph 4(c) and this paragraph 4(d) shall be
allocated among the Company and the MDCP Co-Investors pro rata according to the number of shares of Redeemable Stock to be purchased by each of them. 

        (e)   The
closing of the purchase and sale of the Redeemable Stock pursuant to the Repurchase Option shall take place on the date designated by the Company in the Redemption
Notice or Supplemental Redemption Notice (as the case may be), which date shall not be more than 60 days nor less than five days after the delivery of the later of either such notice to be
delivered. The Company and/or the Investors shall pay for the Redeemable Stock to be purchased pursuant to the Redemption Option by delivery of a check or wire transfer of funds in the aggregate
amount of the purchase price for such shares. The purchasers of Redeemable Stock hereunder shall be entitled to receive customary representations and warranties from the sellers regarding the sellers'
good title to such shares free and clear of any liens or encumbrances). 

        (f)    In
the event that the Company or the MDCP Co-Investors elect to exercise rights to redeem or purchase Redeemable Stock pursuant to this  paragraph 4, the Company or MDCP Co-Investors shall make all
Redeemable Stock acquired pursuant to this  paragraph 4 available for sale to any member of the Company's management approved in accordance with the Management Equity Plan as promptly as
practicable after a transferee has been identified in accordance with the Management Equity Plan; provided that the obligations of the Company and the
MDCP Co-Investors pursuant to this paragraph 4(f) shall be subject to the management member so identified purchasing the Convertible
Shares or Ordinary Shares at the same price, in the same manner and on the same terms on which the Company or the MDCP Co-Investors acquired the Redeemable Stock. 

        (g)   The
right of the Company and the MDCP Co-Investors to repurchase Class D Convertible Shares and Ordinary Shares pursuant to this  paragraph 4 shall terminate upon the earlier of a Sale of the
Company or a Listing. 

        (h)   If
any Corporate Family Member shall cease to be a Corporate Family Member of an Executive, it shall be required forthwith to notify the Company of the fact and the
manner of such cessation and within 30 days thereafter to transfer all Executive Stock held by it to such Executive and/or his Family Members. 

        (i)    The
Company shall be entitled at any time to require any Corporate Family Member to procure the certification to the Company of the persons owning the voting shares of
such Corporate Family Member and of the manner in which appointments of its directors are controlled, and of the beneficial ownership of all shares of such Corporate Family Member entitled to all of
the capital, dividend and other economic interests therein, and to require that such certification shall be supported by appropriate opinions and/or declarations of counsel and directors of such
Corporate Family Member. 

        (j)    If
any Corporate Family Member shall fail to comply with a requirement of the Company made hereunder to the reasonable satisfaction of the Company and within a period
reasonably specified by the Company for compliance, the Company shall be entitled by 30 days notice in writing to such Corporate Family Member to declare that unless it shall have complied with
such requirement to the Company's reasonable satisfaction within the period of such notice, it shall thereupon cease to be a Corporate Family Member and sub-paragraph (h) of this  paragraph 4
shall thereupon have effect. 

8

   
        5.    Restrictions on Transfer.    

        (a)    Transfer of Executive Stock.    No Executive shall sell, transfer, assign, pledge or otherwise dispose of
(whether with or without consideration and whether voluntarily or involuntarily or by operation of law) (a "Transfer") any interest in any shares of
Executive Stock, except pursuant to the provisions of paragraph 4 hereof, this paragraph 5
or in connection with a Sale of the Company, unless otherwise agreed to by the Company. 

        (b)    Certain Permitted Transfers.    The restrictions contained in this  paragraph 5 shall not apply with respect to
transfers of shares of Executive Stock (i) pursuant to applicable laws of descent and
distribution, (ii) to an Executive's Family Member, or (iii) to Corporate Family Members of such Executive; provided that such restrictions shall continue to be applicable to shares of
such Executive Stock after any such transfer and the transferees of such Executive Stock shall have agreed in writing to be bound by the provisions of this Agreement. 

        (c)    Tag-Along Rights.    At least 30 days prior to any sale by any MDCP Co-Investor
of Ordinary Shares, which sale will cause the aggregate number of Ordinary Shares sold by the MDCP Co-Investors and the Co-Investors subsequent to September 17, 2002 to
be more than 25% of the total issued share capital of the Company in any transaction or series of transactions (excluding any Transfer (v) to any Person as an equity kicker in connection with
financing or sales of Preferred Equity Securities in connection with the Take-Over Offer and related transactions, (w) in a Public Sale, (x) to any of its members or
Affiliates or their members, partners, shareholders or Affiliates, (y) to a co-investor (each, a "Co-Investor") on or
prior to September 17, 2003 or (z) to a member of management of the Company and its Subsidiaries (the "Excluded Transfers")), such MDCP
Co-Investor shall deliver written notice (the "Sale Notice") to each Executive specifying in reasonable detail the identity of the
prospective transferee(s), the number of shares to be sold and the terms and conditions of the proposed Transfer. Each Executive may elect to include any Ordinary Shares and Class D Convertible
Shares in the contemplated Transfer at the same price per share and on the same terms by delivering written notice to the MDCP Co-Investors within 30 days after delivery of the Sale
Notice; provided that in the event that an Executive elects to transfer Class D Convertible Shares pursuant to this  paragraph 5(c), the price per
share paid to an Executive in respect of each Class D Convertible Share shall be reduced by the Conversion
Price per share for such Class D Convertible Share and upon such Transfer and the payment of the per share price, each such Class D Convertible Share shall be convertible into one
Ordinary Share upon payment of the Conversion Price per share to the Company. If any Executive has elected to participate in such Transfer, each of the MDCP Co-Investors proposing to make
such Transfer and each such Executive shall be entitled to sell in the contemplated Transfer, at the same price and on the same terms, a number of Ordinary Shares and Class D Convertible Shares
equal to the product of (i) the quotient determined by dividing (A) the percentage of Ordinary Shares and Class D Convertible Shares owned by such Person
by (B) the aggregate percentage of Ordinary Shares and Class D Convertible Shares collectively owned by all persons participating in such Transfer and (ii) the aggregate number of
Ordinary Shares to be sold in the contemplated Transfer. In determining whether the 25% threshold has been crossed, all related Transfers shall be taken into account, but no Excluded Transfers shall
be taken into account. 

For example, if the Sale Notice contemplated a sale of 100 Ordinary Shares, and if the MDCP Co-Investors participating in such Transfer at
such time own 40% of all Ordinary Shares and if an Executive elects to participate and such Executive owns 2% of all Ordinary Shares and if other persons owning an aggregate of 10% of all Ordinary
Shares elect to participate in the contemplated sale, the MDCP Co-Investors would be entitled to sell 76.9 shares (40% ÷ 52% × 100
shares), such Executive would be entitled to sell 3.9 shares (2% ÷ 52% × 100 shares) and the other persons would be entitled to sell 19.2 shares in
the aggregate (10% ÷ 52% × 100 shares). 

9

 

        Notwithstanding
the immediately foregoing sentence, in the event of a Transfer (other than a Transfer in connection with which the Board and the holders of a majority of Ordinary Shares
are exercising their rights pursuant to paragraph 8 hereof) that causes the rights of the Executives pursuant to this  paragraph 5(c) to be
triggered, each Executive shall be entitled to sell in the contemplated Transfer, at the same price and on the same terms, a
number of Ordinary Shares and Class D Convertible Shares equal to the product of (i) the quotient determined by dividing (A) the percentage of Ordinary Shares and Class D
Convertible Shares owned by such Person by (B) the aggregate percentage of Ordinary Shares and Class D Convertible Shares collectively owned by all persons participating in such Transfer
and (ii) the aggregate number of Ordinary Shares to be sold in the contemplated Transfer plus the aggregate number of Ordinary Shares sold by the MDCP Co-Investors and the
Co-Investors in all Transfers (other than Excluded Transfers) prior to the date of the contemplated Transfer. The number of Ordinary Shares and Class D Convertible Shares which an
Executive is entitled to sell pursuant to this paragraph 5(c) shall be subject to ratable cut-back in relation to other executives
that have acquired Ordinary Shares and Class D Convertible Shares (it being understood that in such circumstances, such executives shall have priority over the proposing transferor) in the
event that the number of shares which Executives in the aggregate are entitled to sell in such contemplated Transfer exceeds the number of shares proposed to be sold in the contemplated Transfer. The
rights of the Executives pursuant to this paragraph shall terminate as of the date that the aggregate percentage of shares which the Executives have been entitled to sell pursuant to this  paragraph 5(c) (whether or not exercised) relative to their aggregate holdings of Ordinary Shares and Class D Convertible Shares equals
the aggregate percentage of Ordinary Shares which the MDCP Co-Investors and the Co-Investors have sold in all Transfers plus the contemplated Transfer (after giving effect to
the rights of the Executives pursuant to this sentence) relative to the aggregate holdings of Ordinary Shares held by the MDCP Co-Investors and the Co-Investors. 

        Each
person transferring Ordinary Shares or Class D Convertible Shares pursuant to this paragraph 5(c) shall pay his, her or
its pro rata share (determined on the basis of consideration received or receivable by such person in such transaction relative to the aggregate consideration received or receivable by all
persons participating in such transaction in their capacity as selling stockholders) of the reasonable expenses incurred by the persons transferring shares in connection with such Transfer and shall
be obligated to join in any indemnification or other obligations that the MDCP Co-Investors agree to provide in connection with such Transfer (other than any such obligations that relate
specifically to another person such as indemnification with respect to representations and warranties given by such other person regarding such other person's title to and ownership of Ordinary Shares
and Class D Convertible Shares). Notwithstanding the foregoing, other than with respect to representations and warranties given by such person regarding such person's title to and ownership of
Ordinary Shares and Class D Convertible Shares and covenants regarding such person, (x) the aggregate indemnification obligations or other obligations for which such person shall be
liable shall not exceed such person's pro rata portion (determined on the basis of consideration received or receivable by such person in such transaction relative to the aggregate consideration
received or receivable by all persons participating in such transaction in their capacity as selling stockholders) of such indemnification obligation or other obligation and (y) in no event
shall any holder of Executive Stock be required to assume any indemnification or other obligation in excess of the greater of (A) 50% of the after-tax proceeds received or
receivable by such person as a result of such transaction and (B) the aggregate Acquisition Cost for the equity securities sold by such holder in such transaction. 

        (d)    Termination of Restrictions.    

          (i)  The
restrictions on Transfer and holding of shares of Executive Stock set forth in this paragraph 5 shall
continue with respect to each share of Executive Stock following any Transfer thereof. 

10

 

         (ii)  Notwithstanding
any provision in this Agreement to the contrary, following the consummation of the Company's initial Listing, the restrictions on Transfer of Ordinary
Shares and Class D Convertible Shares set forth in this paragraph 5 shall terminate (A) with respect to Ordinary Shares purchased
pursuant to paragraph 1, as of the date of the Company's initial Listing, and (B) with respect to all other Ordinary Shares and
Class D Convertible Shares in equal tranches on each of December 31, 2005, December 31, 2006 and December 31, 2007. 

        (iii)  The
restrictions on Transfer and holding set forth in this paragraph 5 shall not terminate with respect to any
Class A Convertible Shares, Class B Convertible Shares and Class C Convertible Shares. 

        6.    Participation Rights.    

        (a)   If
the Company proposes to issue any newly issued additional Ordinary Shares (the "New Shares") to the MDCP
Co-Investors or any of their Affiliates or Co-Investors after the date hereof (other than in connection with the consummation of the Exchange) and the MDCP
Co-Investors or such Affiliates or Co-Investors participate in such issuance of New Shares, each Executive shall have the right to purchase on the same terms and conditions a
pro rata portion of the New Shares equal to the product of (i) the total number of New Shares to be issued, multiplied by (ii) a fraction,
(A) the numerator of which is the number of Class D Convertible Shares and Ordinary Shares held by such Executive as of the date hereof and (B) the denominator of which is the
total number of Class D Convertible Shares and Ordinary Shares which are held by all shareholders immediately prior to the proposed issuance. 

        (b)   The
Company shall give each Executive written notice of any proposed issuance of New Shares (the "Option Issuance
Notice") describing the price and terms upon which the Company proposes to issue and sell such New Shares. During the 10-day period following the date of delivery
of the Option Issuance Notice (the "Election Period") each Executive may exercise his, her or its right to purchase New Shares in accordance with this  paragraph 6, for the price and upon the terms and conditions specified in the Option Issuance Notice by giving written notice to the Company and
stating therein the quantity of New Shares to be purchased. 

        (c)   In
the event that any Executive fails to exercise his right to subscribe for any New Shares which it is entitled to subscribe for under this  paragraph 6, the Company shall have 180 days following
the Election Period to issue or enter into an agreement to issue and sell the New
Shares proposed to be sold at a price and upon terms not substantially more favorable to the MDCP Co-Investors, its Affiliates and other prospective subscribers therefor than those
specified in the Option Issuance Notice. In the event the Company has not issued the New Shares or entered into an agreement to issue the New Shares within the said 180-day period, the
Company shall not thereafter issue or otherwise transfer such New Shares without first offering such New Shares to the Executives in the manner provided in this  paragraph 6. 

        (d)   If
an Executive elects to subscribe for any New Shares pursuant to this paragraph 6, the closing of such
subscription shall occur at such time and at such location selected by the Company. 

        (e)   Notwithstanding
anything else to the contrary set forth herein, the provisions of this paragraph 6 shall not apply
to any Excluded Issuances. 

        7.    Additional Restrictions on Transfer.    Each holder of Executive Stock agrees not to effect any public sale or
distribution of any Executive Stock or other equity securities of the Company, or any securities convertible into or exchangeable or exercisable for any of the Company's equity securities, during the
seven days prior to and the 180 days after the effectiveness of any Listing, except as part of such Listing or if otherwise permitted by the Company. 

11

 

        8.    Sale of the Company.    

        (a)   If
the Board and the holders of a majority of the Ordinary Shares approve a Sale of the Company (the "Approved Sale"),
all holders of Executive Stock shall consent to and raise no objections against the Approved Sale, and if the Approved Sale is structured as a sale of stock, the holders of Executive Stock shall agree
to sell their shares of Executive Stock on the terms and conditions approved by the Board and the holders of a majority of Ordinary Shares. The holders of Executive Stock shall take all necessary and
desirable actions in connection with the consummation of the Approved Sale. 

        (b)   The
obligations of the holders of Executive Stock with respect to the Approved Sale are subject to the satisfaction of the following conditions: (i) upon the
consummation of the Approved Sale, all of the holders of Ordinary Shares shall receive the same form and amount of consideration per Ordinary Share, or if any holders of the Ordinary Shares are given
an option as to the form and amount of consideration to be received, all holders shall be given the same option; (ii) no holder of Executive Stock shall be required to join in any
indemnification obligations or other obligations (other than with respect to representations and warranties given by such person regarding such person's title to and ownership of Executive Stock or
covenants with respect to such holder) (A) in excess of such person's pro rata portion (determined on the basis of consideration received or receivable by such holder of Executive Stock in such
transaction relative to the aggregate consideration received or receivable by all holders of the Company's equity securities in their capacity as such) of such indemnification obligations or other
obligations or (B) in excess of the greater of (I) 50% of the after-tax proceeds received or receivable by such person as a result of such transaction and (II) the
aggregate Acquisition Cost for the equity securities sold by such holder in such transaction and (iii) all holders of Class D Convertible Shares shall be given an opportunity to either
(A) exercise their rights to convert to Ordinary Shares prior to the consummation of the Approved Sale and participate in such sale as holders of Ordinary Shares or (B) upon the
consummation of the Approved Sale, receive in exchange for such Class D Convertible Shares consideration equal to the amount determined by multiplying (1) the same amount of
consideration per Ordinary Share received by the holders of Ordinary Shares in connection with the Approved Sale less the Conversion Price per Class D Convertible Share by (2) the number
of Ordinary Shares issuable upon conversion of such Class D Convertible Shares. 

        (c)   Each
holder of Executive Stock shall bear his or her pro rata share (determined on the basis of consideration received or receivable by such holder of Executive Stock in
such transaction relative to the aggregate consideration received or receivable by all holders of the Company's equity securities in their capacity as such) of the costs of any sale of Executive Stock
pursuant to an Approved Sale to the extent such costs are incurred for the benefit of all holders of Ordinary Shares and are not otherwise paid by the Company or the acquiring party. Costs incurred by
each such holder of Executive Stock on his or her own behalf shall not be considered costs of the transaction hereunder. 

        (d)   Notwithstanding
anything else to the contrary set forth herein or the Company's Articles of Association, in the event of a Sale of the Company (whether or not such Sale
of the Company is an Approved Sale), each holder of Executive Stock acknowledges that (i) the consideration to be received in exchange for each Class A Convertible Share, Class B
Convertible Share and Class C Convertible Share that is unvested as of the closing date of the Sale of the Company (after giving effect to any acceleration under paragraph 2(c) hereof)
shall equal the lesser of (x) the amount per share paid to holders of Ordinary Shares in such transaction triggering a Sale of the Company and
(y) the Original Cost for such Convertible Share and (ii) the consideration to be received or receivable in exchange for each Class D Convertible Share shall equal the amount
determined by multiplying (x) the same amount of consideration per Ordinary Share received or receivable by the holders of Ordinary Shares in connection with the Sale of the Company less the
Conversion Price per Class D Convertible Share by (y) the number of Ordinary Shares issuable upon conversion of such Class D Convertible Shares. In 

12

 

furtherance
of the acknowledgments in this paragraph 8(d), each holder of Executive Stock agrees that (A) all unvested Class A
Convertible Shares, Class B Convertible Shares and Class C Convertible Shares which are not vested in connection with a Sale of the Company shall automatically be deemed transferred to a
buyer of the Company and cancelled, without further action on the part of such buyer, the Company or any Executive, in connection with the consummation of such Sale of the Company upon payment by the
buyer or its designee of an amount in cash (or other form of consideration payable in connection with such Sale of the Company) equal to the lesser of
the number of Class A Convertible Shares, Class B Convertible Shares and Class C Convertible Shares held by an Executive multiplied by the amount per share paid to holders of
Ordinary Shares in such transaction triggering a Sale of the Company and the Original Cost for all such unvested Class A Convertible Shares, Class B Convertible Shares and Class C
Convertible Shares and (B) all Class D Convertible Shares which are not converted to Ordinary Shares in connection with such Sale of the Company shall automatically be deemed transferred
to a buyer of the Company and cancelled, without further action on the part of such buyer, the Company or an Executive, in connection with consummation of such Sale of the Company upon payment by the
buyer or its designee of an amount in cash (or other form of consideration payable in connection with such Sale of the Company) equal to the amount determined by multiplying (1) the same amount
of consideration per Ordinary Share received or receivable by the holders of Ordinary Shares in connection with the Approved Sale less the Conversion Price per Class D Convertible Share by
(2) the number of Ordinary Shares issuable upon conversion of such Class D Convertible Shares. 

        9.    Voting Agreement.    So long as the MDCP Co-Investors, their Affiliates and Co-Investors
collectively hold a majority of the Ordinary Shares of the Company, each Executive holding Ordinary Shares shall vote all of his or her Ordinary Shares (and, in the event such holder is entitled to
vote any of the Company's other securities for the election of directors, such
holder shall vote all such securities) and take all other necessary or desirable actions (in such holder's capacity as a stockholder of the Company) as are requested by the MDCP
Co-Investor Majority in order to cause the representatives to be elected as members of the Board as directed by the MDCP Co-Investor Majority. In addition, each holder shall
not vote his or her Ordinary Shares (or other voting securities) in connection with the removal of any MDCP Co-Investor's designees or any other Board member as a director unless and until
the MDCP Co-Investor Majority directs such holder how to vote on such removal. In addition, each holder shall at all such times vote his or her Ordinary Shares (and such other voting
securities) and Convertible Shares on all matters on which they are entitled to vote as directed by the MDCP Co-Investor Majority as long as such vote is not adversely discriminatory to an
Executive or holders of Convertible Shares in a manner different from the MDCP Co-Investor Majority or holders of Ordinary Shares, respectively. The provisions of this paragraph 9
shall terminate as of the effective date of the Company's initial Listing or upon consummation of a Sale of the Company. Notwithstanding anything to the contrary set forth in this paragraph 9,
each holder shall cast all votes in respect of his Ordinary Shares, other voting securities of the Company and Convertible Shares (to the extent that such shares are entitled to vote) in favor of the
conversion of the Company from a public company to a private company or a private company to a public company. 

        10.    Definitions.    

        (a)   "Accelerated Valuation Date" means the first date on which either a Sale of the Company or an initial Listing occurs
(i.e., the date upon which the Sale of the Company is consummated or an initial Listing becomes effective). 

        (b)   "Acquisition Cost" means, with respect to any equity securities, the aggregate subscription price or purchase price for
such securities together with any other amounts contributed to or invested in the Company allocable to such equity securities (with any such investment or contribution that is being used to subscribe
for or purchase securities being allocated to the shares so purchased or subscribed for and with any such investment or contribution that is not being used to subscribe for or 

13

 

purchase
securities being allocated ratably among the Ordinary Shares comprising such equity securities). 

        (c)   "Adjusted EBITDA" means, for any annual period, the consolidated net income of the Company (excluding net income related
to or derived from exceptional items) plus, in each case only to the extent deducted in determining such net income, (i) the amount of the
provision for income taxes for the Company for such period, (ii) the amount of net interest expense of the Company during such period for Indebtedness for Borrowed Money, (iii) the
amount of dividends actually paid by the Company to, or accrued by the Company with respect to, holders of Preferred Equity Securities (other than the Company or one of its Subsidiaries) during such
period, and (iv) depreciation and amortization charges of the Company for such period, all determined on a consolidated basis in accordance with Irish generally accepted accounting principles.
Adjusted EBITDA shall be determined on the basis of the audited consolidated annual financial statements of the Company. 

        (d)   "Affiliate" of any Person, means a Person controlling, controlled by or under common control with such Person. 

        (e)   "Aggregate Equity Price" means the aggregate Acquisition Cost in respect of all Ordinary Shares issued (whether to the
MDCP Co-Investors, pursuant to the Management Equity Plan or other investors) in connection with the settlement of consideration pursuant to the Take-Over Offer and the
refinancing of indebtedness and payment of fees and expenses in connection therewith. 

        (f)    "Applicable Class B Valuation Date" means each of December 31, 2005, December 31, 2006 and
December 31, 2007. 

        (g)   "Applicable Valuation Date" means any Applicable Class B Valuation Date or the Class C Valuation Date. 

        (h)   "Associated Company" means any company having an Equity Share Capital of which not less than 20% in nominal value is
beneficially owned by any Group Company. 

        (i)    "Cash Equivalents" means, as of any date of determination, cash plus cash equivalents of the Company, determined on a
consolidated basis in accordance with Irish generally accepted accounting principles. 

        (j)    "Cash Inflows" shall be calculated (i) in accordance with paragraph 2(c)(v) with respect to
(x) equity securities remaining on an Applicable Class B Valuation Date or a Class C Valuation Date, (y) equity securities sold through the date of a Sale of the Company
and (z) equity securities remaining on the date of a Listing and (ii) for all other purposes by calculating cash payments actually received or receivable by the MDCP
Co-Investors on or prior to the Valuation Date in exchange for their equity securities, whether such payments are received or receivable from the Company or a third party;  provided that in the event any
consideration to be received by the MDCP Co-Investors in connection with any sale of equity securities is
deferred consideration, contingent consideration or non-cash consideration, the Cash Inflows to be received by the MDCP Co-Investors with respect to such deferred
consideration, contingent consideration and/or non-cash consideration shall, solely for purposes of calculating Cash Inflows as of such Accelerated Valuation Date, be determined with
reference to the fair market value thereof as of such Accelerated Valuation Date by a Person appointed by the president of the Institute of Chartered Accountants—England (the
"Appraiser"), whose services shall for this purpose be paid for by the Company and whose determination shall (absent manifest error) be binding and
conclusive; provided further that for purposes of calculating Cash Inflows, no management, closing or other fees paid to the MDCP
Co-Investors or their Affiliates by or on behalf of the Company and/or its Subsidiaries shall be included (other than an amount equal to €38,000,000 multiplied by a
fraction, (x) the numerator of which is the aggregate Acquisition Cost of Ordinary Shares of Jefferson Smurfit Group Limited owned by the MDCP Co-Investors on or prior to
September 17, 2002 less the Acquisition Cost of Ordinary Shares of Jefferson Smurfit Group Limited 

14

 

transferred
by the MDCP Co-Investors to their Co-Investors and its Affiliates on or prior to September 17, 2003 or acquired pursuant to the Management Equity Plan on or
prior to January 17, 2003 and (y) the denominator of which is the Aggregate Equity Price minus the Acquisition Cost of Ordinary Shares of Jefferson Smurfit Group Limited acquired
pursuant to the Management Equity Plan. Notwithstanding the foregoing, for purposes of calculating "IRR" hereunder, "Cash Inflows" shall include amounts received by the MDCP Co-Investors
in any share capital reduction of the Company consummated on or prior to July 31, 2004. 

        (k)   "Cash Outflows" as used herein shall include the sum of the aggregate Acquisition Cost paid by the MDCP
Co-Investors in and to the Company or its Subsidiaries (including, for the avoidance of doubt, Jefferson Smurfit Group Limited). 

        (l)    "Cause" shall mean, with respect to any Executive, (i) the commission of actual or attempted fraud, embezzlement,
theft, misappropriation, serious misconduct or gross default by such Executive against or in respect of a Group Company or such Executive's duties for a Group Company, which relates to a material
amount or which results in a criminal conviction or settlement with criminal penalties or future restrictions or in material loss or damage to that Group Company or other Group Companies;
(ii) the refusal or failure by such Executive to carry out his duties to a Group Company to a material degree, following a written warning that dismissal may result; (iii) conviction of
a crime in relation to the business or assets of a Group Company, which has, in the reasonable opinion of the Board acting in accordance with the recommendation of the Company's chief executive
officer (or chief operating officer where such Executive is the chief executive officer), a material adverse effect upon a Group Company or its shareholders, other than (A) violation of the
Road Traffic Acts and (B) a criminal matter in respect of which such Executive has been indemnified by a Group Company and is entitled to indemnification, (iv) knowing violation of the
Foreign Corrupt Practices Act, or (v) material breach of a material, formal agreement in writing (other than an employment agreement) between such Executive and the Company or the Group Company
by which such Executive is or was employed or serves as an officer or director; provided that for the avoidance of doubt, the termination of an
Executive's employment, or service as an officer or director, by a Group Company shall not be for Cause if it results wholly or mainly from (v) such Executive's death or disability,
(w) such Executive's retirement on grounds of age or pursuant to an early retirement plan of the Group Company that employs the Executive or for which you serve as an officer or director,
(x) such Executive's voluntary resignation (unless such Executive is subject to internal or external proceedings likely to lead to a termination for Cause at the time of such resignation),
(y) such Executive's redundancy, or (z) the Group Company that employs such Executive, or for which Executive serves as an officer, or director, ceasing for any reason to be a Group
Company. 

        (m)  "Class A Convertible Shares" has the meaning given to such term in the Company's Articles of Association. 

        (n)   "Class B Convertible Shares" has the meaning given to such term in the Company's Articles of Association. 

        (o)   "Class C Convertible Shares" has the meaning given to such term in the Company's Articles of Association. 

        (p)   "Class C Valuation Date" means December 31, 2007. 

        (q)   "Class D Convertible Shares" has the meaning given to such term in the Company's Articles of Association. 

        (r)   "Conversion Price" means, with respect to any Class D Convertible Share, the fair market value of an Ordinary
Share as of the date of issue of any Class A Convertible Share, Class B Convertible or Class C Convertible Share which had converted into such Class D Convertible Share
less the amount paid for the Class A Convertible Share, Class B Convertible Share or Class C 

15

 

Convertible
Share which had converted into such Class D Convertible Share; provided that, with respect to each Convertible Share issued upon
consummation of the Exchange, the Conversion Price for the Class D Convertible Share issued upon conversion of such Convertible Share shall be €9.999 per share; provided further
that if the Company shall consummate a share capital reduction on or prior to 31 July 2004 pursuant to S.72, Companies Act 1963 (the "Reduction" and the amount paid to shareholders thereunder
the "Reduction Amount") the Conversion Price for every Class D Convertible Share issuable upon Conversion of any Class A Convertible Share, Class B Convertible Share or
Class C Convertible Share in issue as of the date of the Reduction or within three months thereafter (all such Class D Convertible Shares, the "Relevant D Shares") shall be reduced by an
amount per Relevant D Share calculated according to the following formula: 

€R
= RA + I + C

           N + W 

        Where: 

        R
= the amount of the reduction in Conversion Price per relevant D Share. 

        RA
= the Reduction Amount (the US Dollar portion of which shall be converted to Euro at the exchange rate prevailing on the date of conversion). 

        I
= the aggregate amount of interest accrued or paid (including interest paid by capitalisation pursuant to the agreement relative thereto) to the date upon which R is to be determined
by the Company's subsidiary, JSG Holdings plc, with respect to the indebtedness incurred by it on or prior to the date of the Reduction, for the purposes of on-lending to the Company to
fund the Reduction Amount and of meeting related costs (the "HYD Offering"). 

        C
= the aggregate costs and fees incurred by the Company and JSG Holdings plc to underwriters, financial advisers and legal counsel in connection with the HYD Offering. 

        N
= the number of Ordinary Shares in issue at the date of the Reduction. 

        W
= the number of Ordinary Shares issuable upon exercise of all Warrants of the Company outstanding at the date of the Reduction. 

        In
no event shall the Conversion Price be reduced to less than €0. 

        (s)   "Convertible Shares" means each of the Class A Convertible Shares, Class B Convertible Shares,
Class C Convertible Shares and Class D Convertible Shares. 

        (t)    "Corporate Family Member" in respect of each Executive, any corporate entity in respect of which (i) all of its issued
voting shares; (ii) the right or power of appointment of all of its directors; and (iii) at least 85% of the entire economic interest therein (comprising shares entitling their owners to
capital and dividends in and from such corporate entity) are respectively owned and held (either directly or through other Corporate Family Members) by such Executive and/or those Family Members of
such Executive as are described in clause (i) of the definition of Family Member. 

        (u)   "Eligible Class B Convertible Shares" means Class B Convertible Shares that are (but for the penultimate
sentence of paragraph 2(c)(ii)) scheduled to be eligible for vesting on an Applicable Class B Valuation Date that is after the Accelerated
Valuation Date (i.e., shares not eligible for vesting prior to such Accelerated Valuation Date). 

        (v)   "Equity Share Capital" shall have the meaning assigned in Section 155 of the Companies Act, 1963. 

        (w)  "Excluded Issuances" means the issuance of (i) any Ordinary Shares after the date hereof for management incentive
and/or compensation purposes, (ii) any Ordinary Shares (other than issuances to the MDCP Co-Investors, its Affiliates and the Co-Investors in their capacity as equity
holders of the 

16

 

Company)
issued as consideration for an acquisition or joint venture transaction, (iii) any Ordinary Shares issued as an "equity kicker" in respect of indebtedness for borrowed money or in
respect of Preferred Equity Securities, (iv) any Ordinary Shares issued upon conversion of any of the Convertible Shares, (v) any options, warrants or rights to acquire, or shares
convertible into, Ordinary Shares listed in clauses (i) through (iv), and (vi) Ordinary Shares issued in connection with or pursuant to a Public Sale. 

        (x)   "Executive Stock" shall mean all Ordinary Shares issued or issuable hereunder or acquired hereinafter by any Executive
(including any Ordinary Shares issued or issuable (either directly or indirectly) upon conversion of any Executive's Convertible Shares). Executive Stock shall continue to be Executive Stock in the
hands of any holder other than an Executive (except for the Company and the Co-Investors and except for transferees in a Public Sale), and except as otherwise provided herein, each such
other holder of Executive Stock shall succeed to all rights and be subject to all and obligations attributable to an Executive as a holder of Executive Stock hereunder. Executive Stock shall also
include shares of the Company's capital stock and other securities issued with respect to Executive Stock by way of a stock split, stock dividend or other recapitalization. 

        (y)   "Fair Market Value" of each share of Executive Stock means the average of the closing prices of the sales of Ordinary
Shares on all securities exchanges on which the Ordinary Shares may at the time be listed on the day immediately prior to Executive's termination. If at any time the Ordinary Shares are not listed on
any securities exchange, the Fair Market Value shall be the fair value of the Ordinary Shares determined in good faith by the Board (acting as experts and not arbitrators and without taking into
account the effect of any contemporaneous repurchase of Class A Convertible Shares, Class B Convertible Shares and Class C Convertible Shares under  paragraph 4 hereof). If a
terminated Executive reasonably disagrees with such determination, the Board and such Executive will negotiate in good
faith to agree on such Fair Market Value. If such agreement is not reached within 30 days after the delivery of the Redemption Notice or the Supplemental Redemption Notice, Fair Market Value
shall be determined by the Appraiser, who shall be instructed to submit to the Board and the Executive a report within 30 days of its engagement setting forth such determination. The expenses
of the Appraiser shall be borne by the terminated Executive unless the Appraiser's valuation is not less than 7.5% greater than the amount determined by the Board, in which case, the costs of the
Appraiser shall be borne by the Company. The determination of such Appraiser shall (absent manifest error) be final and binding upon all parties. Notwithstanding the foregoing, the "Fair Market Value"
of any Executive Stock that is a Class A Convertible Share, Class B Convertible Share or Class C Convertible Share shall be the Original Cost for such Convertible Share and the
"Fair Market Value" of any Executive Stock that is a Class D Convertible Share means the Fair Market Value of an Ordinary Share determined in accordance with this definition  minus the Conversion
Price for such Class D Convertible Share. 

        (z)   "Family Member" in respect of each Executive, (i) such Executive's spouse, descendants (whether natural or
adopted), siblings, siblings' descendants and siblings' spouses and any trust solely for the benefit of such Executive and/or such Executive's spouse, descendants, siblings, siblings' descendants
and/or siblings' spouses and (ii) Corporate Family Members of such Executive; provided that in respect of Dr. MW J. Smurfit,
Mrs. Anne Smurfit (the widow of his deceased brother Jefferson Smurfit Junior) shall be deemed to be a sibling for all purposes of this Agreement;  provided further that in respect of Mr. Frank
Doyle, Ms. Catriona Moore shall be deemed to be his spouse for all purposes of this
Agreement. 

        (aa) "5% Owner" means any Person that owns 5% or more of the Company's Ordinary Shares on a fully-diluted basis. 

        (bb) "Group Companies" means the Company, JSG and their respective Subsidiaries and Associated Companies and
"Group Company" means any of the Group Companies. 

17

 

        (cc) "Indebtedness for Borrowed Money" means, with respect to the Company and its Subsidiaries at any date, without
duplication: (i) all obligations of the Company and its Subsidiaries for borrowed money or in respect of loans or advances; (ii) all obligations of the Company and its Subsidiaries
evidenced by bonds, debentures, notes or other similar instruments; (iii) all obligations in respect of letters of credit, whether or not drawn, and bankers' acceptances issued for the account
of the Company and its Subsidiaries; (iv) all capitalized lease liabilities of the Company and its Subsidiaries; (v) all interest rate protection agreements of the Company and its
Subsidiaries (valued on a market quotation basis); (vi) all obligations of the Company and its Subsidiaries secured by a contractual lien; (vii) all guarantees of obligations of Persons
other than Company and its Subsidiaries in connection with any of the foregoing; and (viii) any accrued interest, prepayment premiums or penalties related to any of the foregoing, in each case
calculated as though the payment is made on an Accelerated Valuation Date or Applicable Valuation Date; provided that Indebtedness for Borrowed Money
shall not include any obligations of any of the Company or any of its Subsidiaries, on the one hand, to the Company or any other of its Subsidiaries, on the other hand. 

        (dd) "Independent Third Party" means any Person who, immediately prior to the contemplated transaction, is not a 5% Owner, is
not controlling, controlled by or under common control with any 5% Owner and is not the spouse or descendent (by birth or adoption) of any 5% Owner. 

        (ee) "IRR" means, as of the Applicable Valuation Date, the annual interest rate (compounded quarterly and expressed as a
percentage) which, when used to calculate the net present value as of such Applicable Valuation Date of all Cash Inflows and all Cash Outflows, causes the difference between Cash Inflows and Cash
Outflows to equal zero. The IRR will be calculated in good faith by the Board, which determination shall be conclusive and binding unless the holders of a majority of Convertible Shares (and Ordinary
Shares issued upon conversion of Convertible Shares) then outstanding (the "Majority Holders") reasonably disagree with such calculation and give
written notice of such disagreement within 30 days after the Board has made its determination of IRR (a "Dispute Notice"). If a Dispute Notice is
delivered, the Board and a representative designated by the Majority Holders (the "Representative") will negotiate in good faith to agree on the
calculation of IRR. If such agreement is not reached within 30 days after the delivery of the Dispute Notice, IRR shall be calculated by the Appraiser, which shall be instructed to submit to
the Board and such Executive a report within 30 days of its engagement setting forth such calculation (with it being understood that the Appraiser shall be engaged in reference to the
calculation of IRR (but not with respect to an audit or re-audit of the Company's books and records or the calculation of Total Value and the components thereof)). The expenses of the
Appraiser shall be borne by the Majority Holders unless the Appraiser's IRR calculation is greater than the amount determined by the Board, in which case, the costs of the Appraiser shall be borne by
the Company. The determination of such Appraiser shall (absent manifest error) be final and binding upon all parties. 

        (ff)  "JSG" means Jefferson Smurfit Group Limited, an Irish private limited company. 

        (gg) "Listing" means the admission of all or any part of the Ordinary Shares to the Official List of The Irish Stock Exchange
Limited or the Official List of the UK Listing Authority, and to trading on the market for listed securities of the London Stock Exchange or to trading on the Alternative Investment Market or the
taking effect of any granting of permission to deal in the same on any recognized investment exchange (as that term is used in the Financial Services Act 1986) or the registration of all or any of the
Ordinary Shares (or equivalent securities of any Subsidiary or American Depository Receipts with respect to any of the forgoing) on Form F-1, F-2 or F-3 (or
any similar long-form or short-form registrations) pursuant to the United States Securities Act of 1933 (as amended) or any similar US federal law, or any similar listing or
registration by the Company of the Ordinary Shares on the public stock exchange or securities market in any other jurisdiction. 

18

   
        (hh) "MDCP Co-Investor Majority" means the holders of a majority of the Ordinary Shares held by all MDCP
Co-Investors. 

        (ii)   "MDCP Co-Investors" means, collectively, MDCP IV Global Investments LP, MDCP III Global Investments LP, MDSE
III Global Investments LP and any Affiliate of the foregoing that owns or holds Ordinary Shares as of the date of determination and "MDCP Co-Investor" means any of the MDCP
Co-Investors. 

        (jj)   "Original Cost" of each Ordinary Share issued hereunder in connection with the Exchange shall be equal to
€10 and of each Convertible Share purchased hereunder shall be equal to €0.001, and for any Ordinary Share or Convertible Share issued by the Company after the date
hereof other than in connection with the Exchange shall be the purchase price per share paid therefor as set forth on the signature page executed by Executive and accepted by the Company, in each case
as proportionately adjusted for all subsequent stock splits, stock dividends and other recapitalizations. 

        (kk) "Permitted Transferee" means any holder of Executive Stock who acquired such stock pursuant to a transfer permitted by  paragraph 5(b). 

        (ll)   "Person" means an individual, a partnership, a limited liability company an unlimited liability company, a company
limited by guarantee, a corporation, an association, a joint stock company, a trust, a joint venture, an unincorporated organization and a governmental entity or any department, agency or political
subdivision thereof. 

        (mm) "Preferred Equity Securities" means any equity securities of the Company or any of its Subsidiaries which are limited to
a fixed sum or percentage of stated value in respect to the rights of the holders thereof to participate in dividends or in the distribution of assets upon any liquidation, dissolution or winding up
of the Company or any such Subsidiary. 

        (nn) "Public Sale" means (x) any sale after a Listing in any European Union member state or (y) in the case of
a Listing in the United States, any sale pursuant to a registered public offering under the Securities Act or any sale to the public pursuant to Rule 144 promulgated under the Securities Act
effected through a broker, dealer or market maker. 

        (oo) "Sale of the Company" means the sale of the Company to an Independent Third Party or affiliated group of Independent
Third Parties pursuant to which such party or parties acquire (i) capital stock of the Company possessing the voting power to elect a majority of the Company's board of directors (whether by
merger, consolidation or sale or transfer of the Company's capital stock) or (ii) all or substantially all of the Company's assets determined on a consolidated basis. 

        (pp) "Securities Act" means the Securities Act of 1933, as amended. 

        (qq) "Subsidiary" means, with respect to any Person, any corporation, limited liability company, partnership, association or
other business entity of which (i) if a corporation, not less than 50% of the total voting power of stock entitled (without regard to the occurrence of any contingency) to vote in the election
of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof,
or (ii) if a limited liability company, partnership, association or other business entity, a majority of the partnership or other similar ownership interest thereof is at the time owned or
controlled, directly or indirectly, by any Person or one or more Subsidiaries of that person or a combination thereof. For purposes hereof, a Person or Persons shall be deemed to have a majority
ownership interest in a limited liability company, partnership, association or other business entity if such Person or Persons shall be allocated a majority of limited liability company, partnership,
association or other business entity gains or losses or shall be or control the managing general partner of such limited liability company, partnership, association or other business entity. 

19

 

        (ss)  "Take-Over Offer" means an offer for the entire issued and to be issued share capital of JSG made by the
Company or one of its Subsidiaries. 

        (tt)  "Total Value" means the result equal to (i) six (6) multiplied by Adjusted EBITDA,  plus (ii) Cash Equivalents in excess of €40,000,000 minus
(iii) Indebtedness for Borrowed Money, minus (iv) the aggregate stated value of, plus accrued but unpaid dividends with respect to, any
Preferred Equity Securities. 

        (uu) "Valuation Date" means an Accelerated Valuation Date or an Applicable Valuation Date. 

        11.    Notices.    Any notice provided for in this Agreement must be in writing and must be either personally
delivered, mailed by first class mail (postage prepaid and return receipt requested), sent by reputable
overnight courier service (charges prepaid) or sent by facsimile (hard copy to follow) to the recipient at the address or facsimile number indicated below: 

To the Company: 

c/o
Jefferson Smurfit Group Limited

Headquarters

Beech Hill

Clonskeagh

Dublin 4

Facsimile: 353-1-283-7113 

With copies to: 

Kirkland &
Ellis LLP

200 East Randolph Drive

Chicago, IL 60601

Telephone: (312) 861-2000

Fax: (312) 861-2200

Attn: William S. Kirsch, P.C. 

To Executive: 

At
the address listed below Executive's signature on the signature page attached hereto. 

To the MDCP Co-Investors: 

c/o
Madison Dearborn Partners LLC

Three First National Plaza

Suite 3800

70 W. Madison

Chicago, IL 60602

Telephone: (312) 895-1000

Fax: (312) 895-1056

Attn: Samuel M. Mencoff 

With copies to: 

c/o
Madison Dearborn Partners, LLC

Three First National Plaza

Suite 3800

Chicago, IL 60602

Telephone: (312) 895-1000

Fax: (312) 895-1056

Attn: Samuel M. Mencoff 

20

 

and 

Kirkland &
Ellis LLP

200 East Randolph Drive

Chicago, IL 60601

Telephone: (312) 861-2000

Fax: (312) 861-2200

Attn: William S. Kirsch, P.C. 

or
such other address or facsimile number or to the attention of such other person as the recipient party shall have specified by prior written notice to the sending part. Any notice under this
Agreement shall be deemed to have been given when so delivered or sent or, if mailed, five days after deposit in the mail, two days after being sent by reputable overnight courier service (charges
prepaid) or on the same day if received by facsimile during business hours on a business day (hard copy to follow). 

        12.    General Provisions.    

        (a)    Transfers in Violation of Agreement.    Any Transfer or attempted Transfer of any Executive Stock in violation
of any provision of this Agreement shall be void, and the Company shall not record such Transfer on its books or treat any purported transferee of such Executive Stock as the owner of such stock for
any purpose. 

        (b)    Severability.    Whenever possible, each provision of this Agreement shall be interpreted in such manner as to
be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction,
such
invalidity, illegality or unenforceability shall not affect any other provision or any other jurisdiction, but this Agreement shall be reformed, construed and enforced in such jurisdiction as if such
invalid, illegal or unenforceable provision had never been contained herein. 

        (c)    Complete Agreement.    This Agreement, those documents expressly referred to herein, the Company's Articles of
Association, the Registration Rights Agreement, the Corporate Governance Agreement and, with respect to any employee party to such an employment letter, any employment letter between the Company or
one of its Subsidiaries and an Executive embody the complete agreement and understanding among the parties and supersede and preempt any prior understandings, agreements or representations by or among
the parties, written or oral, which may have related to the subject matter hereof in any way. Notwithstanding the foregoing, nothing herein shall be deemed to amend, supersede or preempt any agreement
of an Executive made in any Acceptance Form included with that certain Exchange Offer information memorandum dated on or about January 19, 2004, including, without limitation, the power of
attorney executed in connection therewith. 

        (d)    Counterparts.    This Agreement may be executed in separate counterparts, each of which is deemed to be an
original and all of which taken together constitute one and the same agreement. 

        (e)    Successors and Assigns.    Except as otherwise provided herein, this Agreement shall bind and inure to the
benefit of and be enforceable by each Executive, the Company, the Investors and their respective successors and assigns (including subsequent holders of Executive Stock); provided that the rights and
obligations of Executive under this Agreement shall not be assignable except in connection with a permitted transfer of Executive Stock hereunder. 

        (f)    Choice of Law.    This Agreement shall be governed by the internal law of Ireland. Any suit or action brought
against any Executive hereunder should be brought exclusively in the courts of Ireland (it being understood that, except as set forth in this sentence, nothing contained in this  subparagraph (f) shall
limit any party's rights to bring any suit against any party (other than any Executive) or with respect to the subject matter
hereof in any other jurisdiction); provided that in the case more than one 

21

 

Executive
is bringing a claim against the Company on a set of related facts, all such claims shall be joined in a single proceeding in Ireland. 

        (g)    Remedies.    Each of the parties to this Agreement (including the Investors) shall be entitled to enforce its
rights under this Agreement specifically, to recover damages and costs (including reasonable attorneys fees) caused by any breach of any provision of this Agreement and to exercise all other rights
existing in its favor. The parties hereto agree and acknowledge that money damages may not be an adequate remedy for any breach of the provisions of this Agreement and that any party may in its sole
discretion apply to an court of law or equity of competent jurisdiction (without posting any bond or
deposit) for specific performance and/or other injunctive relief in order to enforce or prevent any violations of the provisions of this Agreement. 

        (h)    Amendment and Waiver.    The provisions of this Agreement may be amended and waived with respect to any
Executive only with the prior written consent of the Company and the Majority Holders; provided that any such amendment or waiver that adversely discriminates against an Executive in a manner that is
adversely disproportionate to such Executive relative to the Majority Holders shall be effective against such Executive only with the prior written consent of such Executive; provided further that
this Agreement may be amended and waived with respect to the MDCP Co-Investors' rights under this Agreement only with the prior written consent of the MDCP Co-Investor
Majority. 

        (i)    Third-Party Beneficiaries.    Certain provisions of this Agreement are entered into for the benefit of and
shall be enforceable by the MDCP Co-Investors as provided herein. 

        (j)    Business Days.    If any time period for giving notice or taking action hereunder expires on a day which is a
Saturday, Sunday or legal holiday in the state in which the Company's chief executive office is located, the time period shall be automatically extended to the business day immediately following such
Saturday, Sunday or holiday. 

        (k)    Rights of the Company.    Nothing in this Agreement shall interfere with or limit in any way the right of the
Company to terminate an Executive's employment, or service as an officer or director at any time (with or without cause), nor confer upon any Executive any right to continue in the employ of, or to
serve as an officer or director for, the Company for any period of time or to continue his or her present (or any other) rate of compensation, and in the event of his or her termination of employment
or termination of his service as an officer, or director (including, but not limited to, termination by the Company without cause) any portion of such Executive's Convertible Shares that were not
previously vested and convertible shall be forfeited. Nothing in this Agreement shall confer upon any Executive any right to be selected again as a Management Equity Plan participant. 

        (l)    Adjustments.    In the event of a reorganization, recapitalization, stock dividend or stock split, or
combination or other change in the Ordinary Shares, the Board may, in order to prevent the dilution or enlargement of rights granted hereunder, make such adjustments in the number and type of shares
authorized by the Management Equity Plan, the number and type of shares in respect of which the Convertible Shares granted hereunder are convertible and the Conversion Price specified herein as may be
determined to be appropriate and equitable. Any such adjustment shall be subject to confirmation by the Company's auditors. 

        (m)    Effectiveness.    This Agreement shall become effective, with respect to each Executive, upon execution and
delivery of this Agreement by the Company and each such Executive. 

        (n)    Taxes.    The Company shall be entitled, if necessary or desirable, to withhold (or secure or require payment
from an Executive in lieu of withholding) the amount of any withholding or other tax due with respect to any amount payable and/or shares issuable under this Agreement or the Management Equity Plan,
and the Company may defer any payment or issuance unless indemnified to its satisfaction with regard to any tax matter for the amounts payable or shares issuable. Each Executive hereby indemnifies the
Company for any tax, liability, loss, expense or penalty that the 

22

 

Company
incurs as a result of an Executive not paying the aggregate taxes which an Executive is required to pay in respect of the Convertible Shares issued hereunder or the Ordinary Shares issued in
respect thereof (including, in each case, upon sale or disposition thereof). Prior to withholding any amount or requiring any indemnification from any Executive, the Company shall consult with the
Executive and his tax advisors regarding the withholding and the indemnification requested. 

        (p)    Tax Advice.    Each Executive will consult with his or her own tax advisor regarding the tax treatment of the
Ordinary Shares and the Convertible Shares (it being understood that the Company is not giving an opinion with respect to nor guaranteeing, and shall not be deemed to be giving an opinion with respect
to nor guaranteeing, any tax results or consequences). Without limiting the generality of the foregoing, nothing herein shall prohibit the Company from making any filings or reports it reasonably
believes may be required to be made with local governmental authorities in respect of the Convertible Shares or the Ordinary Shares issued or issuable hereunder (including upon sale or disposition
thereof). 

        13.    Listing.    In the event that the Board and the holders of a majority of the Ordinary Shares (voting as a
single class) then outstanding approve a Listing, each Executive shall take all necessary or desirable actions in connection with the consummation of the Listing as requested by the Company. In the
event that such Listing is an underwritten offering and the managing underwriters advise the Company in writing that in their opinion the capital stock structure would adversely affect the
marketability of the offering, each Executive shall consent to and vote for a recapitalization, reorganization and/or exchange of Ordinary Shares into securities that the managing underwriters, the
Board and the holders of a majority of the Ordinary Shares then outstanding (voting as a single class) find acceptable, and each Executive shall take all necessary or desirable actions in connection
with the consummation of the recapitalization, reorganization and/or exchange as requested by the Company: provided that the resulting securities reflect and are consistent with the rights and
preferences set forth in the Company's Articles of Association as in effect immediately prior to such Listing. 

        14.    Certificates.    In the event that any Executive requests or demands that the Company issue one or more
certificates representing the shares of Executive Stock purchased hereunder, the Company may require that the certificate be registered in the name of a nominee or custodian designated by the Company
(the "Nominee"), and that, as a condition to such issuance, the Nominee will enter into an agreement with the Company and the MDCP
Co-Investor Majority which shall include, among other things, a provision that the Nominee will not Transfer such Executive Stock except in strict accordance with the terms of this
Agreement (in which case the Nominee shall give prior written notice of such Transfer to the Company and the MDCP Co-Investor Majority) without the prior written consent of the Company and
MDCP Co-Investor Majority. In the event
that the Nominee does not agree to enter into an agreement with the Company, each holder of Executive Stock irrevocably agrees that the Company shall be entitled to retain the certificates
representing such Executive Stock in furtherance of such holder's obligations hereunder. 

*
* * * * 

23

 

        IN
WITNESS WHEREOF, this Management Equity Agreement has been executed as of the date first written above. 

	 	 	JSG PACKAGING LIMITED
	

 	
 	

By:	

	

 	
 	

Its:	

24

 

	 	 	For signature by individuals
	

 	
 	

Signature:

	 	 	Name:

	 	 	(please print)
	 	 	For signature by partnerships, corporations or other entities
	

 	
 	

Name:

	 	 	(please print)
	 	 	Ordinary Shares:             
	 	 	Class A Convertible Shares:             
	 	 	Class B Convertible Shares:             
	 	 	Class C Convertible Shares:             
	 	 	Class D Convertible Shares: 0

25

QuickLinks

MANAGEMENT EQUITY AGREEMENTQuickLinks
 -- Click here to rapidly navigate through this document

Exhibit 4.11  

 
 

REGISTRATION RIGHTS AGREEMENT    
    

        THIS REGISTRATION RIGHTS AGREEMENT (this "Agreement") is made as of February 6, 2004, among JSG Packaging
Limited, a private limited company registered under the laws of the Republic of Ireland (the "Company"), each of the MDCP Co-Investors and
each of the Persons listed on the Schedule of Minority Investors attached hereto (each a "Minority Investor" and collectively, the
"Minority Investors"). The MDCP Co-Investors and the Minority Investors are collectively referred to herein as the
"Investors" and individually as an "Investor". Capitalized terms used but not otherwise defined herein
have the meanings set forth in Section 7 hereof. 

        WHEREAS,
Jefferson Smurfit Group Limited (formerly MDCP Acquisitions Limited) (the "Prior Parent") and the Investors are parties to that
certain Amended and Restated Registration Rights Agreement, dated as of September 5, 2002 (the "Existing Agreement"); and 

        WHEREAS,
on or about the date hereof, holders of Ordinary Shares of Prior Parent, nominal value €0.001 per share (the "Prior Parent Ordinary
Share") are exchanging each such Prior Parent Ordinary Share for one Ordinary Share of the Company (the "Exchange"); 

        WHEREAS,
the parties desire, that upon effectiveness of the Exchange, the Investors be granted the registration rights set forth herein. 

        NOW,
THEREFORE, in consideration of the mutual promises made herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties
hereto, intending to be legally bound, agree as follows: 

        1.    Demand Registrations.    

        (a)    Requests for Registration.    

        (i)    At
any time prior to the Company's Initial Public Offering, the holders of a majority of the MDCP Co-Investor Registrable Securities may request registration
under the Securities Act of all or any portion of their Registrable Securities on Form S-1 or any similar long-form registration (a
"Long-Form Registration"). 

        (ii)   At
any time after the Company's Initial Public Offering, the holders of a majority of the MDCP Co-Investor Registrable Securities may request three
Long-Form Registrations and, if available, an unlimited number of registrations under the Securities Act of all or any portion of their Registrable Securities on
Form S-2 or Form S-3 or any similar short-form registration ("Short-Form Registrations"). 

        Each
such request for registration under this Section 1(a) is referred to herein as a "Demand
Registration." All requests for Demand Registrations shall be made by giving written notice to the Company (the "Demand
Notice"). Each Demand Notice shall specify the approximate number of Registrable Securities requested to be registered and the anticipated per share price range for such
offering. Within ten days after receipt of any Demand Notice, the Company shall give written notice of such requested registration to all other holders of Registrable Securities and, subject to the
provisions of Section 1(e) below, shall include in such registration all Registrable Securities with respect to which the Company has received
written requests for inclusion therein within 20 days after the receipt by such holders of the Company's notice. 

        (b)    Expense.    The Company shall pay all Registration Expenses of all holders of Registrable Securities in all
Demand Registrations. 

        (c)    Long-Form Registrations.    A registration shall not count as one of the permitted
Long-Form Registrations until it has become effective or if the holders of Registrable Securities initially requesting such registration are not able to register and sell at least ninety
percent (90%) of the Registrable Securities requested to be included in such registration; provided that the 

 

Company
shall in any event pay all Registration Expenses in connection with any registration initiated as a Demand Registration whether or not it has become effective and whether or not such
registration has counted as one of the permitted Long-Form Registrations. All Long-Form Registrations shall be underwritten registrations unless otherwise requested by the
holders of a majority of the Registrable Securities included in such registration. 

        (d)    Short-Form Registrations.    Demand Registrations shall be Short-Form Registrations
whenever the Company is permitted to use any applicable short form. After the Company has become subject to the reporting requirements of the Exchange Act, the Company shall use its best efforts to
make Short-Form Registrations on Form S-2 or Form S-3 (or any successor form) available for the sale of Registrable Securities. 

        (e)    Priority on Demand Registrations.    The Company shall not include in any Demand Registration any securities
which are not Registrable Securities without the prior written consent of the holders of a majority of the Registrable Securities included in such registration. If a Demand Registration is an
underwritten offering and the managing underwriters advise the Company in writing that in their opinion the number of Registrable Securities and, if permitted hereunder, other securities requested to
be included in such offering exceeds the number of Registrable Securities and other securities, if any, which can be sold in an orderly manner in such offering within a price range acceptable to the
holders of a majority of the Registrable Securities initially requesting registration, the Company shall include in such registration the number which can be so sold in the following order of
priorities: (i) first, among the Registrable Securities, if any, requested to be included in such registration, pro rata among the holders of such Registrable Securities on the basis of the
number of Registrable Securities owned by each such holder (but in no event greater than the amount requested to be included by such holder) and (ii) second, other securities requested to be
included in such registration. 

        (f)    Restrictions on Long-Form Registrations.    The Company shall not be obligated to effect any Demand
Registration which is a Long-Form Registration within 180 days after the effective date of a previous Demand Registration which was a Long-Form Registration or a
previous registration in which the holders of Registrable Securities were given piggyback rights pursuant to Section 2 and in which there was no
reduction in the number of Registrable Securities requested to be included therein. The Company may postpone for up to 180 days the filing or the effectiveness of a registration statement for a
Demand Registration if the Board determines in its reasonable good faith judgment that such Demand Registration would reasonably be expected to have a material adverse effect on any proposal or plan
by the Company or any of its Subsidiaries to engage in any material acquisition of assets (other than in the ordinary course of business) or any material merger, consolidation, tender offer,
reorganization or similar transaction; provided that in such event, the holders of Registrable Securities initially requesting such Demand Registration
shall be entitled to withdraw such request and, if such request is withdrawn, such Demand Registration shall not count as one of the permitted Demand Registrations hereunder and the Company shall pay
all Registration Expenses in connection with such withdrawn registration. The Company may delay a Demand Registration hereunder only once in any twelve-month period. 

        (g)    Selection of Underwriters.    Subject to the approval of the holders of a majority of the MDCP
Co-Investor Registrable Securities, the Board shall select the investment banker(s) and manager(s) to administer any underwritten offering pursuant to this  Section 1. 

        (h)    Other Registration Rights.    The Company represents and warrants that it is not a party to, or otherwise
subject to, any other agreement granting registration rights to any other Person with respect to any securities of the Company. Except as provided in this Agreement (including  Section 8(d)), the
Company shall not grant to any Person the right to request the Company to register any equity securities of the Company, or
any securities convertible or exchangeable into or 

2

 

exercisable
for such securities, without the prior written consent of the holders of a majority of the MDCP Co-Investor Registrable Securities (or, if there are no MDCP
Co-Investor Registrable Securities, Registrable Securities); provided that the Company may grant rights to other Persons to participate in
Piggyback Registrations so long as such rights are subordinate to the rights of the holders of Registrable Securities with respect to such Piggyback Registrations; and provided further that no such
grant will treat holders of a different class of Registrable Securities in an adversely different manner without the consent of the holders of a majority of such class of Registrable Securities. Each
holder of Other Registrable Securities irrevocably agrees that a grant of demand registration rights or piggyback registration rights to any Person does not treat holders of Other Registrable
Securities in an adversely different manner from holders of MDCP Co-Investor Registrable Securities as long as upon any underwriters cut-back in connection with any such
registration, holders of Other Registrable Securities and MDCP Co-Investor Securities are cut back ratably vis-à-vis each other based on the number
of Registrable Securities requested to be included by such holders in such registration. 

        2.    Piggyback Registrations.    

        (a)    Right to Piggyback.    Whenever the Company proposes to register any of its securities under the Securities Act
(whether pursuant to a Demand Registration or otherwise), other than pursuant to a registration statement on Form S-4 or Form S-8 or any successor form (a
"Piggyback Registration"), the Company shall give prompt written notice (in any event within five business days after its receipt of notice of any
exercise of demand registration rights) to all holders of Registrable Securities and all holders of Class D Convertible Shares party to this Agreement of its intention to effect such a
registration (including, to the extent known, a reasonable description of the terms thereof) and shall, subject to the provisions of Sections 2(c) and  2(d)
below, include in such registration all Registrable Securities with respect to which the Company has received written requests for inclusion
therein within 20 days after the receipt by such holders of the Company's notice. 

        (b)    Piggyback Expenses.    The Registration Expenses of the holders of Registrable Securities shall be paid by the
Company in all Piggyback Registrations. 

        (c)    Priority on Primary Registrations.    If a Piggyback Registration is an underwritten primary registration on
behalf of the Company, and the managing underwriters advise the Company in writing that in their opinion the number of securities requested to be included in such registration exceeds the number which
can be sold in an orderly manner in such offering within a price range acceptable to the Company, the Company shall include in such registration: (i) first, the securities the Company proposes
to sell; (ii) second, among the Registrable Securities, if any, requested to be included in such registration, pro rata among the holders of such Registrable Securities on the basis of the
number of Registrable Securities owned by each such holder (but in no event greater than the amount requested to be included by such holder); and (iii) third, other securities requested to be
included in such registration. 

        (d)    Priority on Secondary Registrations.    If a Piggyback Registration is an underwritten secondary registration
on behalf of holders of the Company's securities, and the managing underwriters advise the Company in writing that in their opinion the number of securities requested to be included in such
registration exceeds the number which can be sold in an orderly manner in such offering within a price range acceptable to the holders of a majority of such securities initially requesting such
registration, the Company shall include in such registration: (i) first, among the Registrable Securities, if any, requested to be included in such registration, pro rata among the holders of
such Registrable Securities on the basis of the number of Registrable Securities owned by each such holder (but in no event greater than the amount requested to be 

3

 

included
by such holder); and (ii) second, other securities requested to be included in such registration. 

        (e)    Withdrawal.    If as a result of any pro-ration pursuant to paragraphs (c) or (d) of this  Section 2, any holder of
Registrable Securities shall not be permitted to include in a registration all of the Registrable Securities that such
holder had requested to be included, such holder may elect to either withdraw its request for inclusion or reduce the number of Registrable Securities to be included in such registration, provided
such election is made, in writing and irrevocably, reasonably in advance of the execution of any underwriting agreement or custody agreement relating to such registration. 

        (f)    Selection of Underwriters.    Subject to the approval of the holders of a majority of the MDCP
Co-Investor Registrable Securities, the Board shall select the investment banker(s) and manager(s) to administer any underwritten offering pursuant to this  Section 2. 

        (g)    Other Registrations.    If the Company has previously filed a registration statement with respect to
Registrable Securities pursuant to Section 1 or pursuant to this Section 2, and if such
previous registration has not been withdrawn or abandoned, the Company shall not file or cause to be effected any other registration of any of its equity securities or securities convertible or
exchangeable into or exercisable for its equity securities under the Securities Act (except on Form S-8 or any successor form), whether on its own behalf or at the request of any
holder or holders of such securities, until a period of at least 180 days has elapsed from the effective date of such previous registration. 

        3.    Registration Procedures.    Whenever the holders of Registrable Securities have requested that any Registrable
Securities be registered pursuant to this Agreement, the Company shall use its best efforts to effect the registration and the sale of such Registrable Securities in accordance with the intended
method of disposition thereof, and pursuant thereto the Company shall as expeditiously as possible: 

        (a)   prepare
and file with the SEC a registration statement with respect to such Registrable Securities and use its best efforts to cause such registration statement to
become effective (provided that before filing a registration statement or prospectus or any amendments or supplements thereto, the Company shall furnish to the counsel selected by the holders of a
majority of the MDCP Co-Investor Registrable Securities (or if there are no MDCP Co-Investor Registrable Securities, Registrable Securities) covered by such registration
statement copies of all such documents proposed to be filed, which documents shall be subject to the review and comment of such counsel); 

        (b)   notify
each holder of Registrable Securities of the effectiveness of each registration statement filed hereunder and prepare and file with the SEC such amendments and
supplements to such registration statement and the prospectus used in connection therewith as may be necessary to keep such registration statement effective for a period of not less than
180 days and otherwise comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement during such period in accordance
with the intended methods of disposition by the sellers thereof set forth in such registration statement; 

        (c)   furnish
to each seller of Registrable Securities such number of copies of such registration statement, each amendment and supplement thereto, the prospectus included in
such registration statement (including each preliminary prospectus) and such other documents as such seller may reasonably request in order to facilitate the disposition of the Registrable Securities
owned by such seller; 

        (d)   use
its best efforts to register or qualify such Registrable Securities under such other securities or blue sky laws of such jurisdictions as any seller reasonably
requests and do any and all 

4

 

other
acts and things which may be reasonably necessary or advisable to enable such seller to consummate the disposition in such jurisdictions of the Registrable Securities owned by such seller
(provided that the Company shall not be required to (i) qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify but for this subsection,
(ii) subject itself to taxation in any such jurisdiction or (iii) consent to general service of process in any such jurisdiction); 

        (e)   notify
each seller of such Registrable Securities, at any time when a prospectus relating thereto is required to be delivered under the Securities Act, of the happening
of any event as a result of which
the prospectus included in such registration statement contains an untrue statement of a material fact or omits any fact necessary to make the statements therein not misleading, and, at the request of
any such seller, the Company shall prepare a supplement or amendment to such prospectus so that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus shall not
contain an untrue statement of a material fact or omit to state any fact necessary to make the statements therein not misleading; 

        (f)    cause
all such Registrable Securities to be listed on each securities exchange on which similar securities issued by the Company are then listed and, if not so listed,
to be listed on the Nasdaq and, if listed on the Nasdaq, use its best efforts to secure designation of all such Registrable Securities covered by such registration statement as a Nasdaq "national
market system security" within the meaning of Rule 11Aa2-1 of the SEC or, failing that, to secure Nasdaq authorization for such Registrable Securities and, without limiting the
generality of the foregoing, to arrange for at least two market makers to register as such with respect to such Registrable Securities with the National Association of Securities Dealers; 

        (g)   provide
a transfer agent and registrar for all such Registrable Securities not later than the effective date of such registration statement; 

        (h)   enter
into such customary agreements (including underwriting agreements in customary form) and take all such other actions as the holders of a majority of the MDCP
Co-Investor Registrable Securities (or if there are no MDCP Co-Investor Registrable Securities, Registrable Securities) being sold or the underwriters, if any, reasonably
request in order to expedite or facilitate the disposition of such Registrable Securities (including effecting a share split, a combination of shares or other recapitalization); 

        (i)    make
available for inspection by any seller of Registrable Securities, any underwriter participating in any disposition pursuant to such registration statement and any
attorney, accountant or other agent retained by any such seller or underwriter, all financial and other records, pertinent corporate documents and properties of the Company, and cause the Company's
officers, directors, employees and independent accountants to supply all information reasonably requested by any such seller, underwriter, attorney, accountant or agent in connection with such
registration statement; 

        (j)    otherwise
use its best efforts to comply with all applicable rules and regulations of the SEC, and make available to its security holders, as soon as reasonably
practicable, an earnings statement covering the period of at least twelve months beginning with the first day of the Company's first full calendar quarter after the effective date of the registration
statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder; 

        (k)   permit
any holder of Registrable Securities which holder, in its sole and exclusive judgment, might be deemed to be an underwriter or a controlling person of the
Company, to participate in the preparation of such registration or comparable statement and to require the 

5

 

insertion
therein of material, furnished to the Company in writing, which in the reasonable judgment of such holder and its counsel should be included; 

        (l)    in
the event of the issuance of any stop order suspending the effectiveness of a registration statement, or of any order suspending or preventing the use of any related
prospectus or suspending the qualification of any securities included in such registration statement for sale in any jurisdiction, the Company shall use its best efforts promptly to obtain the
withdrawal of such order; 

        (m)  obtain
a cold comfort letter from the Company's independent public accountants and an opinion from the Company's outside counsel, each in customary form and covering
such matters of the type customarily covered by cold comfort letters and legal opinions, respectively, as the holders of a majority of the MDCP Co-Investor Registrable Securities (or if
there are no MDCP Co-Investor Registrable Securities, Registrable Securities) being sold reasonably request; 

        (n)   use
its best efforts to cause such Registrable Securities covered by such registration statement to be registered with or approved by such other governmental agencies or
authorities as may be necessary to enable the sellers thereof to consummate the disposition of the Registrable Securities; and 

        (o)   take
such other actions—including causing such officers of the Company and its Subsidiaries as are requested by the managing underwriters to participate in
"road shows" or similar marketing efforts conducted by such underwriters in connection with any underwritten offering pursuant hereto—as the holders of a majority of the MDCP
Co-Investor Registrable Securities (or if there are no MDCP Co-Investor Registrable Securities, Registrable Securities) being sold reasonably request. 

        4.    Registration Expenses.    

        (a)    Expenses.    All expenses incident to the Company's performance of or compliance with this Agreement, including
all registration and filing fees, fees and expenses of compliance with securities or blue sky laws, printing expenses, messenger and delivery expenses, fees and disbursements of custodians, and fees
and disbursements of counsel for the Company and all independent certified public accountants, underwriters (excluding discounts, commissions and transfer taxes) and other Persons retained by the
Company (all such expenses being herein called "Registration Expenses"), shall be borne as provided in this Agreement, except that the Company shall, in
any event, pay its internal expenses (including all
salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit or quarterly review, the expense of any liability insurance and the expenses
and fees for listing the securities to be registered on each securities exchange on which similar securities issued by the Company are then listed or on the Nasdaq. 

        (b)    Reimbursement of Counsel.    In connection with each Demand Registration and each Piggyback Registration, the
Company shall reimburse the holders of Registrable Securities included in such registration for (i) the reasonable fees and disbursements of one counsel chosen by the holders of a majority of
the MDCP Co-Investor Registrable Securities (or, if none, Registrable Securities) included in such registration and (ii) the reasonable fees and disbursements of each additional
counsel retained by any holder of Registrable Securities solely for the purpose of rendering a legal opinion to underwriters on behalf of such holder in connection with any underwritten Demand
Registration or Piggyback Registration. 

        (c)    Payment of Certain Expenses by Holders of Registrable Securities.    Underwriting discounts and commissions and
transfer taxes relating to the Registrable Securities included in any registration hereunder, and all fees and expenses of counsel for any holder of Registrable 

6

 

Securities
(other than fees and expenses to be reimbursed by the Company as set forth in Section 4(b) above) shall be borne and paid by the
holders of such Registrable Securities. 

        5.    Indemnification.    

        (a)    Indemnification Obligations of the Company.    The Company agrees to indemnify, to the extent permitted by law,
each holder of Registrable Securities participating in an offering pursuant to this Agreement, its officers, directors, partners, employees, advisors and agents and each Person that controls such
holder (within the meaning of the Securities Act) against all losses, claims, damages, liabilities and expenses caused by any untrue or alleged untrue statement of material fact contained in any
registration statement, prospectus or preliminary prospectus or any amendment or supplement thereto relating to such offering or any omission or alleged omission of a material fact required to be
stated therein or necessary to make the statements therein not misleading, except insofar as the same are caused by or contained in any information furnished in writing to the Company by such holder
expressly for use therein or by such holder's failure to deliver a copy of the prospectus or any amendments or supplements thereto after the Company has furnished such holder with a sufficient number
of copies of the same. In connection with an underwritten offering, the Company shall indemnify such underwriters, their officers, directors, partners, employees, advisors and agents and each Person
who controls such underwriters (within the meaning of the Securities Act) to the same extent as provided above with respect to the indemnification of the holders of Registrable Securities. 

        (b)    Indemnification Obligations of Holders of Registrable Securities.    In connection with any registration
statement in which a holder of Registrable Securities is participating, each such holder shall furnish to the Company in writing such information and affidavits as the Company reasonably requests for
use in connection with any such registration statement, related prospectus or preliminary prospectus or any amendment or supplement thereto and, to the extent permitted by law, shall indemnify the
Company, its directors, officers, partners, employees, advisors and agents and each Person who controls the Company (within the meaning of the Securities Act) against any losses, claims, damages,
liabilities and expenses resulting from any untrue or alleged untrue statement of material fact contained in such registration statement, prospectus, preliminary prospectus, amendment or supplement or
any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, but only to the extent that such untrue statement or
omission is contained in any information or affidavit so furnished in writing expressly for use therein by such holder; provided that the obligation to
indemnify shall be individual, not joint and several, for each holder and shall be limited to the net amount of proceeds received by such holder from the sale of Registrable Securities pursuant to
such registration statement. 

        (c)    Indemnification Procedures.    Any Person entitled to indemnification hereunder shall (i) give prompt
written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any Person's right to
indemnification hereunder to the extent such failure has not prejudiced the indemnifying party) and (ii) unless in such indemnified party's reasonable judgment a conflict of interest between
such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the
indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement or compromise made by the indemnified party without its consent (but such
consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more
than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist 

7

 

between
such indemnified party and any other of such indemnified parties with respect to such claim. 

        (d)    Other Indemnification Provisions; Contribution.    The indemnification provided for under this Agreement shall
remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer, director, partner, employee, advisor, agent or controlling Person of such
indemnified party and shall survive the transfer of securities. The Company also agrees to make such provisions, as are reasonably requested by any indemnified party, for contribution to such party in
the event the Company's indemnification is unavailable for any reason such that such provisions provide the same obligations and benefits to the indemnified party as those which would have been
applicable had the indemnification provisions in Sections 5(a) and 5(b) been available taking
into account all of the limitations set forth in Sections 5(a) and 5(b). 

        6.    Participation; Holdback.    

        (a)   No
Person may participate in any registration hereunder which is underwritten unless such Person (i) agrees to sell such Person's securities on the basis provided
in any underwriting arrangements approved by the Person or Persons entitled hereunder to approve such arrangements and (ii) completes and executes such questionnaires, powers of attorney,
indemnities, underwriting agreements and other documents as are customary and reasonably required under the terms of such underwriting arrangements;  provided that no holder of Registrable Securities
included in any underwritten registration shall be required to make any representations or warranties
to the Company or the underwriters (other than customary representations and warranties regarding such holder and such holder's intended method of distribution) or to undertake any indemnification
obligations to the Company with respect thereto, except as otherwise provided in Section 5(b) hereof, or to the underwriters with respect
thereto. 

        (b)   Without
limiting the generality of Section 5(a), no holder of Registrable Securities shall effect any public sale
or distribution of any Registrable Securities or of any other capital stock or equity securities of the Company, or any securities convertible into or exchangeable or exercisable for such stock or
securities, during the seven days prior to and the 180-day period beginning on the effective date of any underwritten Demand Registration or any underwritten Piggyback Registration unless
the underwriters managing the registration otherwise agree; provided that (without limiting the provisions of any other lock-up to which a
holder of Registrable Securities may be subject) in the event that the underwriters managing the registration agree to release any holder of Registrable Securities from the provisions of this  Section 6(b) with respect to all or any portion of such holder's Registrable Securities, such release shall be effective only if each holder is
ratably (based on the number of Registrable Securities held by each such holder) released from the provisions of this Section 6(b). The
restrictions on the transfer of Registrable Securities set forth in this Section 6(b) shall continue with respect to each Registrable Security
until the date on which such Registrable Security has been transferred in a Public Sale. 

        7.    Definitions.    

        "Affiliate" means, with respect to any Person, any other Person controlling, controlled by or under common control with such Person or any
other Person that is a Permitted Transferee of such Person within the meaning of the Shareholders Agreement. 

        "Board" means the Company's board of directors. 

        "Class D Convertible Shares" shall have the meaning given to such term in the Company's Articles of Association. 

8

   
        "Convertible Shares" shall have the meaning given to such term in the Company's Articles of Association. 

        "Exchange Act" mans the United States Securities Exchange Act of 1934, as amended from time to time. 

        "Family Group" means any Minority Investor's spouse, descendants (whether natural or adopted), siblings and siblings' descendants and any
trust solely for the benefit of a Minority Investor and/or such Minority Investor's spouse, descendants, siblings and/or siblings' descendants. 

        "Initial Public Offering" means the initial sale of Ordinary Shares to the public registered under the Securities Act on
Form S-1 or any similar form. 

        "MDCP Co-Investor Registrable Securities" means all Registrable Securities held by the MDCP Co-Investors and their
respective Affiliates and, to the extent agreed to in writing by the holders of a majority of the MDCP Co-Investor Registrable Securities, any of their transferees, successors or assigns. 

        "MDCP Co-Investors" means, collectively, MDCP IV Global Investments LP, MDCP III Global Investments LP, MDSE III Global
Investments LP and any Affiliate of the foregoing that owns or holds Ordinary Shares as of the date of determination and "MDCP Co-Investor" means any of the MDCP Co-Investors. 

        "Ordinary Shares" means the Company's Ordinary Shares, nominal value €0.001 per share, or any shares into which the
Ordinary Shares are converted or exchanged. 

        "Other Registrable Securities" means, collectively, all Registrable Securities other than the MDCP Co-Investor Registrable
Securities; provided that, without the consent of the holders of a majority of the MDCP Co-Investor Registrable Securities, Other
Registrable Securities shall not include any Ordinary Shares held by any Person other than a Minority Investor or any of its Affiliates or Family Group. 

        "Permitted Transferee" has the meaning given to such term in the Shareholders Agreement. 

        "Person" means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, a trust, a
joint venture, an unincorporated organization and a governmental entity or any department, agency or political subdivision thereof. 

        "Public Sale" means any sale of Registrable Securities to the public pursuant to an offering registered under the Securities Act or to the
public through a broker, dealer or market maker pursuant to the provisions of Rule 144 adopted under the Securities Act. 

        "Registrable Securities" means (i) any Ordinary Shares held by any party hereto (or issued upon conversion of any Class D
Convertible Shares of the Company held by any party hereto), (ii) any Ordinary Shares issued or issuable with respect to the securities referred to in clause (i) by way of a share
dividend or share split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization or otherwise;  provided that with respect to any Registrable
Securities, such securities shall cease to be Registrable Securities (x) when they have been
distributed to the public pursuant to an offering registered under the Securities Act or sold to the public through a broker, dealer or market maker in compliance with Rule 144 under the
Securities Act (or any similar rule promulgated by the SEC then in force) and (y) unless otherwise consented to by the holders of a majority of the MDCP Co-Investor Registrable
Securities, when any Registrable Securities are held by any Person other than a MDCP Co-Investor, a Minority Investor or any of their respective Affiliates or Family Group. 

        "SEC" means the United States Securities and Exchange Commission. 

9

 

        "Securities Act" means the United States Securities Act of 1933, as amended from time to time. 

        "Shareholders Agreement" means that certain Exchange and Shareholders Agreement, dated as of February 6, 2004, by and among the
Company, the MDCP Co-Investors and certain other Investors party thereto from time to time. 

        "Subsidiary" means, with respect to any Person, any corporation, limited liability company, partnership, association or other business
entity of which (i) if a corporation, a majority of the total voting power of
stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by
that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (ii) if a limited liability company, partnership, association or other business entity, a
majority of the partnership or other similar ownership interest thereof is at the time owned or controlled, directly or indirectly, by any Person or one or more Subsidiaries of that person or a
combination thereof. For purposes hereof, a Person or Persons shall be deemed to have a majority ownership interest in a limited liability company, partnership, association or other business entity if
such Person or Persons shall be allocated a majority of limited liability company, partnership, association or other business entity gains or losses or shall be or control the managing general partner
of such limited liability company, partnership, association or other business entity. Reference to any "Subsidiary" of the Company shall be given effect only at such times as the Company has one or
more Subsidiaries. 

        8.    Miscellaneous.    

        (a)    No Inconsistent Agreements.    The Company shall not hereafter enter into any agreement with respect to its
securities which is inconsistent with or violates the rights granted to the holders of Registrable Securities in this Agreement. 

        (b)    Adjustments Affecting Registrable Securities.    The Company shall not take any action, or permit any change to
occur, with respect to its securities which would materially and adversely affect the ability of the holders of Registrable Securities to include such Registrable Securities in a registration
undertaken pursuant to this Agreement or which would materially and adversely affect the marketability of such Registrable Securities in any such registration (including effecting a share split or a
combination of shares). 

        (c)    Remedies.    Any Person having rights under any provision of this Agreement shall be entitled to enforce such
rights specifically, to recover damages caused by reason of any breach of any provision of this Agreement and to exercise all other rights granted by law. The parties hereto agree and acknowledge that
money damages may not be an adequate remedy for any breach of the provisions of this Agreement and that any party may in its sole discretion apply to any court of law or equity of competent
jurisdiction (without posting any bond or other security) for specific performance and for other injunctive relief in order to enforce or prevent violation of the provisions of this Agreement. 

        (d)    Amendments and Waivers.    Except as otherwise provided herein, the provisions of this Agreement may be amended
or waived only upon the prior written consent of the Company and the holders of a majority of the MDCP Co-Investor Registrable Securities (or if there are no MDCP Co-Investor
Registrable Securities, Registrable Securities); provided that if any such amendment or waiver would adversely affect the holders of any class of
Registrable Securities relative to the holders of Registrable Securities voting in favor of such amendment or waiver (including the holders of Other Registrable Securities relative to the holders of
MDCP Co-Investor Registrable Securities), such amendment or waiver shall also require the approval of the holders of a majority of the class of Registrable Securities (treating the Other
Registrable Securities as a separate class for this purpose) held by all holders so adversely affected. Each party hereto agrees that each Person issued Ordinary Shares or Convertible Shares by the
Company pursuant to the 

10

 

Company's
2004 Management Equity Plan shall, without the consent of any other Investor party hereto, be entitled to registration rights as a Minority Investor hereunder by execution of a counterpart
to this Agreement and, upon such joinder, each Person party hereto shall be a Minority Investor for all purposes of this Agreement (and the Schedule of
Investors shall be updated accordingly). Furthermore, each party hereto agrees that each Person to whom any MDCP Co-Investor transfers MDCP Co-Investor
Registrable Securities shall, without the consent of any other Investor party hereto, be entitled to registration rights as a holder of Other Registrable Securities, or if consented to by the MDCP
Co-Investor Majority, MDCP Co-Investor Registrable Securities. 

        (e)    Successors and Assigns.    All covenants and agreements in this Agreement by or on behalf of any of the parties
hereto shall bind and inure to the benefit of the respective successors and assigns of the parties hereto whether so expressed or not. Without limiting the foregoing, the Company shall not engage in a
merger, business combination or other extraordinary transaction in which it is not the surviving parent company, and shall not transfer all or substantially all of its assets to another company or
entity, unless the successor parent company or entity expressly assumes all of the Company's obligations hereunder. In addition, whether or not any express assignment has been made, the provisions of
this Agreement which are for the benefit of purchasers or holders of Registrable Securities are also for the benefit of, and enforceable by, any subsequent holder of Registrable Securities. The rights
and obligations of the MDCP Co-Investors under this Agreement and the agreements contemplated hereby may be assigned by the MDCP Co-Investors at any time, in whole or in part,
to any investment fund controlling, controlled by or under common control with the MDCP Co-Investors, or any successor thereto or to any co-investment vehicle for the benefit
of all or some of the employees of Madison Dearborn Partners, LLC or any successor thereto. 

        (f)    Severability.    Whenever possible, each provision of this Agreement shall be interpreted in such manner as to
be effective and valid under applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent
of such prohibition or invalidity, without invalidating the remainder of this Agreement. 

        (g)    Counterparts.    This Agreement may be executed simultaneously in two or more counterparts, any one of which
need not contain the signatures of more than one party, but all such counterparts taken together shall constitute one and the same Agreement. Any Person may at any time after the date hereof, with the
prior written approval of the holders of a majority of the MDCP Co-Investor Registrable Securities (or if there are no MDCP Co-Investor Registrable Securities, Registrable
Securities) and the Company, become a party to this Agreement by executing a counterpart to this Agreement agreeing to be bound by the provisions hereof as if such Person were an original signatory
hereto (which joinder shall not constitute a modification, amendment, or waiver hereof). 

        (h)    Descriptive Headings; Interpretation; No Strict Construction.    The descriptive headings of this Agreement are
inserted for convenience only and do not constitute a substantive part of this Agreement. Whenever required by the context, any pronoun used in this Agreement shall include the corresponding
masculine, feminine or neuter forms, and the singular forms of nouns, pronouns, and verbs shall include the plural and vice versa. Reference to any agreement, document, or instrument means such
agreement, document, or instrument as amended or otherwise modified from time to time in accordance with the terms thereof, and if applicable hereof. The use of the words "include" or "including" in
this Agreement shall be by way of example rather than by limitation. The use of the words "or," "either" or "any" shall not be exclusive. The parties hereto have participated jointly in the
negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if 

11

 

drafted
jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any of the provisions of this Agreement. 

        (i)    Governing Law.    The Agreement and the exhibits and schedules hereto shall be governed by and construed in
accordance with the laws of the State of New York. 

        (j)    Notices.    All notices, demands or other communications to be given or delivered under or by reason of the
provisions of this Agreement shall be in writing and shall be deemed to have been given when delivered personally to the recipient, one day after being sent to the recipient by reputable express
courier service by overnight mail (charges prepaid) or by facsimile (receipt confirmed). Such notices, demands and other communications shall be sent to the Investors and to the Company at the address
indicated below: 

If to the Company: 

c/o
Jefferson Smurfit Group Limited

Headquarters

Beech Hill

Clonskeagh

Dublin 4

Facsimile:            353-1-283-7113 

with copies to:

the
MDCP Co-Investors (at the address indicated below) 

    and:

Kirkland &
Ellis LLP

200 East Randolph Drive

Chicago, IL 60601

USA

Attention:            William S. Kirsch, P.C.

Facsimile:            (312) 861-2200 

If to the MDCP Co-Investors:

c/o
Madison Dearborn Partners, LLC

Three First National Plaza, Suite 3800

70 W. Madison

Chicago, Illinois 60602

USA

Attention:            Samuel M. Mencoff

Facsimile:            (312) 895-1001 

with a copy to:

Kirkland &
Ellis LLP

200 East Randolph Drive 

Chicago, IL 60601

USA

Attention:            William S. Kirsch, P.C.

Facsimile:            (312) 861-2200 

12

 

If to any Minority Investor:

To
the address set forth on the Schedule of Minority Investors attached hereto 

with a copy to:

c/o
William Fry Solicitors

Fitzwilton House

Wilton Place

Dublin 2

Ireland

Attention:            Owen O'Connell

Facsimile:            +353-1-639-5333 

or
to such other address or to the attention of such other person as the recipient party has specified by prior written notice to the sending party. 

        (k)    Business Days.    If any time period for giving notice or taking action hereunder expires on a day which is a
Saturday, Sunday or legal holiday in the United States, the time period shall automatically be extended to the business day immediately following such Saturday, Sunday or legal holiday. 

        (l)    Delivery by Facsimile.    This Agreement, the agreements referred to herein, and each other agreement or
instrument entered into in connection herewith or therewith or contemplated hereby or thereby, and any amendments hereto or thereto, to the extent signed and delivered by means of a facsimile machine,
shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof
delivered in person. At the request of any party hereto or to any such agreement or instrument, each other party hereto or thereto shall reexecute original forms thereof and deliver them to all other
parties. No party hereto or to any such agreement or instrument shall raise the use of a facsimile machine to deliver a signature or the fact that any signature or agreement or instrument was
transmitted or communicated through the use of a facsimile machine as a defense to the formation or enforceability of a contract and each such party forever waives any such defense. 

        (m)    Entire Agreement.    This Agreement embodies the complete agreement and understanding among the parties hereto
with respect to the subject matter hereof and supersedes and preempts any prior understandings, agreements or representations by or among the parties, written or oral, which may have related to the
subject matter hereof in any way (including, without limitation, the Existing Agreement). 

        (n)    Effectiveness.    This Agreement shall become effective and binding upon each party upon execution and delivery
of this Agreement by each of the Company and such party. 

*    *    *    *    * 

13

        IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the date first written above. 

	 	 	JSG PACKAGING LIMITED
	

 	
 	

By:	
 	

 
	 	 	 	 	

	 	 	Its:	 	 
	 	 	 	 	

	

 	
 	

MDCP IV GLOBAL INVESTMENTS LP
	

 	
 	

By:	
 	

MDP IV Global GP, LP
	 	 	Its:	 	General Partner
	

 	
 	

By:	
 	

MDP Global Investors Limited
	 	 	Its:	 	General Partner
	

 	
 	

By:	
 	

 
	 	 	 	 	

	 	 	Its:	 	 
	 	 	 	 	

	

 	
 	

MDCP III GLOBAL INVESTMENTS LP
	

 	
 	

By:	
 	

MDP III Global GP, LP
	 	 	Its:	 	General Partner
	

 	
 	

By:	
 	

MDP Global Investors Limited
	 	 	Its:	 	General Partner
	

 	
 	

By:	
 	

 
	 	 	 	 	

	 	 	Its:	 	 
	 	 	 	 	

	

 	
 	

MDSE III GLOBAL INVESTMENTS LP
	

 	
 	

By:	
 	

MDP III Global GP, LP
	 	 	Its:	 	General Partner
	

 	
 	

By:	
 	

MDP Global Investors Limited
	 	 	Its:	 	General Partner
	

 	
 	

By:	
 	

 
	 	 	 	 	

	 	 	Its:	 	 
	 	 	 	 	

[Signature Page to Registration Rights Agreement]

	 	 	BACCHANTES TWO LIMITED
	

    	
 	

 	
 	

 
	 	 	
 By: Dr. Michael W.J. Smurfit
	

 	
 	

 Gary McGann
	

 	
 	

 Anthony P.J. Smurfit
	

 	
 	

 Ian J. Curley

[Signature Page to Registration Rights Agreement]

	 	 	For signature by individuals
	

 	
 	

Signature:	
 	

 
	 	 	 	 	 	 	

	

 	
 	

Name:	
 	

 	
 	

 
	 	 	 	 	
 (please print)
	

 	
 	
For signature by partnerships, corporations or other entities
	

 	
 	

Name:	
 	

 	
 	

 
	 	 	 	 	
 (please print)
	

 	
 	

Signature:	
 	

 
	 	 	 	 	 	 	

	 	 	Name:	 	 	 	 
	 	 	 	 	
 (please print)

[Signature Page to Registration Rights Agreement]

SCHEDULE OF MINORITY INVESTORS

Bacchantes
Two Limited

15-19 Athol Street

Douglas, Isle of Man 

Gary
McGann

Cherryfield

Stonehouse

Donnybrook

Dublin 4 

Anthony
P.J. Smurfit

Fournaughts

Johnstown

Naas

Co Kildare 

Ian
J. Curley

1 Mount Salus

Knocknacree Road

Dalkey

Co Dublin 

Mid-Ocean
Europe GP (Jersey) Limited

Mid-Ocean Partners

3rd Floor

1 Chester Street

London SW1X 7HP

Attention: Hugh Briggs 

J.P.
Morgan Partners Global Investors, L.P.

J.P. Morgan Partners

1221 Avenue of the Americas, 39th Floor

New York, NY 10020

Attention: Robert Ruggiero 

J.P.
Morgan Partners Investors (Cayman), L.P.

J.P. Morgan Partners

1221 Avenue of the Americas, 39th Floor

New York, NY 10020

Attention: Robert Ruggiero 

J.P.
Morgan Partners Global Investors A, L.P.

J.P. Morgan Partners

1221 Avenue of the Americas, 39th Floor

New York, NY 10020

Attention: Robert Ruggiero 

J.P.
Morgan Partners Global Investors

(Cayman) II, L.P.

J.P. Morgan Partners

1221 Avenue of the Americas, 39th Floor

New York, NY 10020

Attention: Robert Ruggiero 

J.P.
Morgan Partners (BHCA), L.P.

J.P. Morgan Partners

1221 Avenue of the Americas, 39th Floor

New York, NY 10020

Attention: Robert Ruggiero 

Arthur
Street Portfolio, L.P.

Merrill Lynch Private Equity Partners

800 Scudders Mill Road

Plainsboro, NJ 08536

Attention: Mike Cerminaro 

Arthur
Street Fund, L.P.

Merrill Lynch Private Equity Partners

800 Scudders Mill Road

Plainsboro, NJ 08536

Attention: Mike Cerminaro 

Vesey
Street Portfolio, L.P.

Merrill Lynch Private Equity Partners

800 Scudders Mill Road

Plainsboro, NJ 08536

Attention: Mike Cerminaro 

Vesey
Street Fund, L.P.

Merrill Lynch Private Equity Partners

800 Scudders Mill Road

Plainsboro, NJ 08536

Attention: Mike Cerminaro 

Passage
Portfolio, L.P.

Merrill Lynch Private Equity Partners

800 Scudders Mill Road

Plainsboro, NJ 08536

Attention: Mike Cerminaro 

Northwestern
University

Investment Office

633 Clark Street, Crown 1-209

Evanston, IL 60208

Attention: Du H. Chai 

Techline
Investment Ltd.

GIC Special Investments Pte Ltd

156 West 56th Street

Suite 190

New York, NY 10019

Attention: David L. Chiang 

Teachers
Insurance and Annuity Association of

America

TIAA-CREF

730 Third Avenue

New York, NY 10017

Attention: Holly D. Holtz 

BVCF
IV, L.P.

Adams Street Partners

One North Wacker

Suite 2200

Chicago, IL 60606-2807

Attention: David S. Timson 

TCW/Crescent
Mezzanine Trust

TCW/Crescent Mezzanine, LLC

200 Crescent Court

Suite 1600

Dallas, TX 75201

Attention: Tim Costello 

TCW/Crescent
Mezzanine Partners III, L.P.

TCW/Crescent Mezzanine, LLC

200 Crescent Court

Suite 1600

Dallas, TX 75201

Attention: Tim Costello 

TCW
Crescent Mezzanine Partners III

Netherlands, L.P

TCW/Crescent Mezzanine, LLC

200 Crescent Court

Suite 1600

Dallas, TX 75201

Attention: Tim Costello 

Stanley
Shuman

Allen & Company

711 5th Avenue

New York, NY 10022

Macxe
LLC

Allen & Company

711 5th Avenue

New York, NY 10022 

Eran
Ashany

Allen & Company

711 5th Avenue

New York, NY 10022 

Walter
O'Hara, Jr.

Allen & Company

711 5th Avenue

New York, NY 10022 

Robert
Dean

Allen & Company

711 5th Avenue

New York, NY 10022 

Schwerin
Company, L.L.C.

Michael Schwerin

President

One
Bayview Avenue

Oyster Bay, New York 11771 

Paul
Magnell

CEO

Bay State Paper Company

892 River Street

Hyde Park, MA 02136 

Special
Co-Invest I

Madison Dearborn Partners, LLC

Three First National Plaza

Suite 3800

Chicago, Illinois 60602

Attention: David Mosher 

QuickLinks

REGISTRATION RIGHTS AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}]]